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Peptidyl-prolyl isomerase Pin1 is a key protein in many regulatory processes in 
the mammalian cell. By catalyzing conformational changes in over 50 critical proteins, 
it participates in a diverse array of cellular processes, including cell cycle control, 
transcription / splicing regulation, DNA replication checkpoint control, DNA damage 
response, neuronal survival, and germ cell development. Deregulation of Pin1 has 
been implicated in several human diseases. Notably, overexpression of Pin1 is 
prevalent in many human cancers; whereas its inhibition induces apoptosis and 
contributes to neuronal death in Alzheimer’s disease. Pin1 specifically catalyzes 
cis/trans-isomerization of proline in the target sequence of phosphorylated 
Ser/Thr-Pro. Very little is known about its catalytic mechanism and its interaction 
with its biological substrates.  
 
In the current studies, crystal structures of seven Pin1 mutants of previously 
reported functionally important residues, including R14A, F25A, S32A, W34A, 
K63A, C113A, and M130A, are solved and compared to the published wild-type 
structures. Structures of R14A, F25A, and S32A mutants exhibited side chain shifts in 
residues Arg-14, Arg-17, His-27, Arg-21, Gln-66, and Lys-117, suggesting the 
formers’ potential roles in substrate binding. Conformation at the active site of the 
C113A and M130A structures was identical to the wild-type structure even though 
without a bound substrate at the site. Our CD analyses show a decreased melting 
 7
temperature for C113A and M130A. Together, these suggest that Cys-113 and 
Met-130 contribute to the stability of Pin1’s core structure. This region could be very 
rigid to serve as a critical selectivity filter for substrate binding. The α1/β1 loops of all 
the mutants are in a closed conformation although there is no sulphate or phosphate 
ion recruited to the PPIase catalytic site. This observation contradicts a previously 
proposed “induced-fit” model. Here, we propose a “two-step induced-fit” binding 
model. In this model, substrate binding to the WW domain induces the opening of the 
α1/β1 loop through Arg-14 and Phe-25 for the recruitment of a second recognition 
motif to the catalytic site. This second binding in turn induces the closure of α1/β1 
loop, followed by substrate conformational change through cis/trans-isomerization of 
proline. Lastly, Pin1 nuclear localization could result from its interaction with cellular 
substrates. Interestingly, the W34A mutant caused Pin1 translocation to the cytosol in 
all cell cycle stages, indicating the in vivo relevance of Trp-34 in substrate binding.   
 
In summary, the work reported in this dissertation provided new information on 
certain key residues with their contribution to Pin1 core structure stability, local 
secondary structures and its subcellular distribution. These revealed novel insights of 
how Pin1 interacts with its biological target proteins, which could perhaps aid 
effective rational drug design.  
 
Keywords: Pin1, isomerization, α1/β1 loop, “two-step induced-fit” binding model, 
melting temperature, translocation 
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CHAPTER 1: A LITERATURE REVIEW ON THE STRUCTURE AND FUNCTION 
RELATIONSHIP OF PIN1 
1.1 Introduction 
 Peptidyl-prolyl isomerase (PPIase) Pin1 (EC 5.2.1.8) is an essential protein 
in regulating entry into mitosis by catalyzing the conformational change of a number 
of critical regulatory proteins. Structurally and functionally, Pin1 is a novel prolyl 
isomerase and specifically catalyzes cis/trans-isomerization of proline in the sequence 
of phosphorylated Ser/Thr-Pro (pSer/Thr-Pro). Ser/Thr-Pro is a major regulatory 
phosphorylation motif that functions in diverse cellular processes, and it has long 
been believed that Ser/Thr phosphorylation regulates the function of proteins by 
inducing conformational changes. Yet, little is known about how phosphorylation 
actually induces the conformational change. The identification of Pin1 has revealed a 
novel post-phosphorylation regulatory mechanism, in which Pin1 induces the 
conformational change of proteins through its specific isomerase activity towards 
pSer/Thr-Pro motifs, thereby regulating protein function (Lu et al., 2002a; Lu et al., 
1996b; Ranganathan et al., 1997; Yaffe et al., 1997). 
 
Intensive studies on Pin1 had revealed a wide range of critical proteins 
essential in cell cycle regulation to be its biological substrates. Deregulation of Pin1 
has been implicated in pathological conditions including cancers and 
neurodegenerative diseases (Wulf et al., 2005). Hence, comprehensive biochemical, 
cellular, functional and structural studies have been carried out to understand the 
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mechanism of Pin1 in regulating the activity of its biological substrates. 
 
1.2 The peptidyl-prolyl isomerase (PPIase) family 
Peptidyl-prolyl isomerases (PPIases) are ubiquitous proteins expressed in 
prokaryotic and eukaryotic cells. They are enzymes that catalyze the interconversion 
of cis/trans conformations of certain peptidyl prolyl bonds in proline-containing 
peptide chains. These enzymes were originally identified as helper enzymes for 
accelerating the restructuring of polypeptide backbones to promote native folding of 
newly synthesized proteins (Fischer et al., 1998; Schiene and Fischer, 2000). To date, 
based on sequence homology and drug specificity, PPIases have been classified into 
three families, namely cyclophilins (CyPs), FK506-binding protein (FKBPs), and 
parvulins. CyPs and FKBPs selectively bind the immunosuppressant drugs 
cyclosporine A (CsA) and FK506 / rapamycin, respectively. CyPs and FKBPs are 
hence also known as immunophilins, and they are implicated in immune functions. 
Recent studies have recognized that they act by sequestering calcineurin, rather than 
having an immune system-specific action (Shaw, 2002). Moreover, CyPs and FKBPs 
are also involved in neuroprotection or neuroregeneration activities, Ca2+-mediated 
intracellular signaling, chaperone activities, and HIV infection (Wang and Etzkorn, 
2006). On the other hand, unlike CyPs and FKBPs, members of the parvulin family, 
which include the Escherichia coli (E. coli) protein parvulin, the Drosophila dodo 
gene product, the Arabidopsis protein At-Pin1at, human protein hPar14 and the focus 
of the thesis, Pin1, do not bind immunosuppressant drugs. They have instead been 
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shown to be important for cell cycle progression (Shaw, 2002).  
 
These three families of PPIases are also structurally distinct. CyPs consist of eight 
antiparallel β-strands wrapping around a barrel surface that forms a compact 
hydrophobic pocket in which CsA binds (Ke et al., 1991). FKBPs, in contrast, are 
characterized by an amphipathic, five-stranded β-sheet that wraps around a single 
short α-helix (Van Duyne et al., 1991; Michnick et al., 1991). PPIase domain of 
parvulins folds into a half β-barrel, consisting of four antiparallel β-strands 
surrounded by four α-helices (Ranganathan et al., 1997). 
 
1.3 Pin1 discovery and historical perspectives 
 The human PPIase Pin1 was first identified in 1996 by yeast two-hybrid screens 
as a protein that binds to and suppresses the toxicity of Never-In-Mitosis A (NIMA), a 
fungal mitotic kinase that is phosphorylated on multiple pSer/Thr-Pro motifs and 
induces mitotic catastrophe in eukaryotic cells (Lu et al., 1996a; Lu and Hunter, 1995; 
Ye et al., 1995). Hence, it is given the name as Pin1 (Protein (peptidyl-prolyl cis/trans 
isomerase) NIMA-interacting 1). Subsequent studies revealed that Pin1 specifically 
binds to and isomerizes pSer/Thr-Pro motifs, in a large and defined subset of 
phosphoproteins (Lu et al., 1999b; Ranganathan et al., 1997; Yaffe et al., 1997). This 
specificity of Pin1 is not observed for other two well-known families of PPIases. 
Hence, Pin1 was classified into the parvulin family of PPIases, whose enzymatic 
activity can be irreversibly inhibited by the compound juglone 
(5-hydroxy-1,4-naphthoquinone) (Rahfeld et al., 1994b; Rudd et al., 1995; Lu et al., 
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1996b). Interestingly, within the parvulin family of PPIases, bacterial and mouse 
parvulins, as well as human hPar14 have no activity towards pSer/Thr-Pro bonds, and 
their phosphorylated function remains unknown (Uchida et al., 1999). Thus, the 
parvulin family can be further subdivided into Pin1-type PPIases and Parvulin-type 
PPIases (Lu et al., 2002a). 
 
 Human Pin1 encodes a polypeptide of 163 amino acid residues in length with a 
molecular weight of 18,000 Dalton and is ubiquitously expressed (Lu et al., 1996b). It 
is a nuclear protein and mainly localizes at nuclear speckles. Pin1 is highly conserved 
among the eukaryotes. Among its homologues, human Pin1 shares 95% identity to 
mouse Pin1, 87% to Xenopus Pin1, 57% to Drosophila Dodo, 46% to yeast Ptf1/Ess1, 
51% to fungi Ssp1, and 51% to plant At-Pin1at (Fujimori et al., 1999; Hani et al., 
1995; Landrieu et al., 2002; Maleszka et al., 1996; Kops et al., 1998; Winkler et al., 
2000). In contrast to cyclophilins and FKBPs for which deletion in yeast is non-lethal, 
Ptf1/Ess1 or Pin1 is essential for growth in several genetic backgrounds in budding 
yeast and in several human cancer cell lines. For examples, the depletion of Pin1 or 
inhibition of its PPIase activity in these cells result in mitotic arrest and apoptosis 
(Rippmann et al., 2000). In Xenopus extracts, Pin1 depletion causes premature G2/M 
transition and a DNA replication defect (Winkler et al., 2000). In mouse, disruption of 
Pin1 gene results in a range of severe cell proliferative defects. On the other hand, 
overexpression of Pin1 causes G2/M arrest in HeLa cells and in Xenopus extracts (Lu 
et al., 1996b; Shen et al., 1998; Osmani et al., 1988). These observations have 
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initiated interest on Pin1, and Pin1 was first suggested to be an essential cell cycle 
regulator involved in G2/M transition and M-phase exit (Albert et al., 2004).  
 
Nevertheless, some findings which question Pin1’s essentiality have emerged. For 
example, disruption of Pin1 gene in mice, and of its homologues in Drosophila and 
fission yeast, is not lethal, although the mutants do display some interesting 
phenotypes (Maleszka et al., 1996; Campbell et al., 1997). For example, Pin1 null 
Drosophila displays a severe oogenic defect, and fission yeast mutation has a 
synthetic growth defect with mutations of Cdc25 or Wee1. The mutant fission yeast is 
also hypersensitive to inhibitors of phosphatase or cyclophilins. Interestingly, in one 
strain of budding yeast, Ptf1/Ess1 disruption permits the mutant cells to grow more 
slowly compared to wild-type cells and the mutant displays elevated level of 
cyclophilin A, as in the case in Ptf1/Ess1 knockout fission yeast. Furthermore, 
overexpression of cyclophilin A can rescue the Pin1 phenotype. These results suggest 
that Pin1 and cyclophilin A might have some overlapping functions under certain 
conditions. Besides, there are multiple Pin1-like genes in plants and more than one 
Pin1-related gene in Drosophila. Thus, other functionally overlapping Pin1-like genes 
or even other structurally distinct phosphorylation-specific PPIases may exist in 
higher eukaryotic cells to explain why Pin1 gene is not essential in some model 
organisms (Campbell et al., 1997).  
 
1.4 A unique role in the pSer/Thr-Pro conformational switch 
 Proline has a distinctive five-carbonyl ring structure, where its three-carbon side 
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chain is linked back to the nitrogen atom of its backbone. Thus, the peptide bond of 
the prolyl residue in relation to an adjacent phosphorylated site in a native protein is 
able to populate two markedly distinct cis and trans conformations (Figure 1-1) (Wulf 
et al., 2005). Typically, the pSer/Thr-Pro peptide bond that is stable in the cis 
conformation in a protein is estimated to be ~10-20% (Zhou et al., 2000). Moreover, 
rotation around the prolyl peptide bonds is energetically unfavored, with a ~22 
kcal/mol energy barrier due to their partial double-bond character (Ranganathan et al., 
1997). Thus, interconversion between the cis and trans onformations could be a major 
rate-limiting step for many biological processes because the distinct isomeric 
structures may interact with different cellular proteins. Phosphorylation on 
Ser/Thr-Pro motifs further restrains this conversion.  
 
Isomerization of the pSer/Thr-Pro motifs is important because they are the only 
phosphorylation motifs known for almost all proline-directed protein kinases. 
Proline-directed phosphorylation mediated by the kinases plays an essential role in 
normal cell proliferation and in malignant transformation. In fact, many oncogenes 
and tumour suppressors are directly regulated by proline-directed phosphorylation (Lu, 
2003). Degenerated peptide screen demonstrated that Pin1 specifically catalyzes 
cis/trans-isomerization of proline in the sequence of pSer/Thr-Pro motif (Yaffe et al., 
1997). This motif specificity implies that Pin1 plays a unique and excellent role in the 
regulation of signaling cascades associated with proline-directed phosphorylation. 
Isomerization of pSer/Thr-Pro motifs between cis and trans conformation mediated 
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by Pin1 can significantly affect the local or even the global tertiary structure of the 
target protein. This could have profound effects on the target molecules, allowing the 
turning on and off of signaling cascades with high efficiency and precise timing, in 
dynamic cellular processes such as cell division. This post-phosphorylation regulatory 
machinery provided another layer of post-translational regulation upon 
phosphorylation-dependent regulation (Lu et al., 2002a). Interestingly, most 
pSer/Thr-Pro motifs in Pin1 targets are located in the regulatory domains of the 




Figure 1-1: Peptidyl-prolyl cis/trans isomerization and PPIases. (Adapted from Lu et al. 
(2002), Trends in Cell Biology, 12(4): 164-172) 
 
The biological significance of such post-phosphorylation regulatory mechanism 
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becomes even more obvious as seen in the conformation specificity of 
proline-directed protein kinases and phosphatases. Indeed, protein kinases such as 
mitogen-activated protein kinases (MAPKs), cyclin-dependent protein kinase 2 
(Cdk2), and a major phosphatase, protein phosphatase 2A (PP2A), phosphorylate or 
dephosphorylate preferentially the trans conformation of Ser/Thr-Pro motifs. 
pSer/Thr-Pro motifs in the cis conformation are energetically less favourable, but as 
mentioned earlier, exist at a level of ~10-20 % physiologically, as a result of 
spontaneous isomerization. Thus, PPIases are needed to convert these conformers to 
trans isomers. A novel regulatory mechanism for phosphorylation signaling has been 
revealed, whereby a protein kinase deposits a phosphate group onto a protein, the 
isomerase induces a conformational change that facilitates removal of the phosphate 
group by a phosphatase to control the function and activity of the phosphoproteins 
with efficiency and precise timing (Lu et al., 2002a).  
 
1.5 Biological substrates of Pin1 
 Comprehensive studies have revealed that Pin1 participates in many essential 
cellular processes, including mitotic regulation, DNA replication checkpoint control, 
DNA damage response, transcription / splicing regulation, cell survival / apoptosis, 
germ cell development, and immune response. This is done by Pin1’s interaction with 
a wide range of target proteins, whereby it regulates a spectrum of activities such as 
catalysis, protein-protein interactions, subcellular localization, protein 
dephosphorylation, and protein stability amongst its targets (Wulf et al., 2005).  
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There are more than 50 Pin1 substrates identified so far through recent 
comprehensive biochemical, biological and structural studies. These include cell cycle 
regulated protein Raf-1 (Dougherty et al., 2005), Cdc25 (Zhou et al., 2000; 
Stukenberg and Kirschner, 2001), Cyclin D1 (Liou et al., 2002), Cyclin E (Yeh et al., 
2006), GTP-binding protein Rab4 (Yaffe et al., 1997; Gerez et al., 2000), 
anti-apoptotic protein Bcl-2 (Basu et al., 2002; Basu and Haldar, 2002; Pathan et al., 
2001), transcription factors c-Jun (Wulf et al., 2001), β-catenin (Ryo et al., 2001), 
NFAT (Liu et al., 2001), p53 (Berger et al., 2005; Zheng et al., 2002; Zacchi et al., 
2002; Wulf et al., 2002), c-Myc (Yeh et al., 2004), p73 (Mantovani et al., 2004), c-fos 
(Monje et al., 2005), and Alzheimer’s disease related proteins APP (Pastorino et al., 
2006), and Tau (Lu et al., 1999a; Smet et al., 2004). This list is of course not 
exhaustive, and is summarized in Table 1-1. 
 
1.6 Regulation of Pin1 expression and activity 
 While Pin1 is participating in such a diverse cellular processes, it is known to be 
tightly regulated at both transcriptional and post-translational levels. At the 
transcriptional level, growth factors or other stimulating factors such as the activated 
Neu or Ras stimulate the E2F family of transcription factors. E2F in turn enhance 
transcription of Pin1 gene. Like many other E2F target genes, Pin1 transcripts and its 
protein levels fluctuate during cell cycle progression in non-transformed cells. In 
transformed cells, however, Pin1 level is constitutively high (Shen et al., 1998; Ryo et 
al., 2002).  
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At the post-translational level, regulation of Pin1 activity is mediated by its 
phosphorylation at Ser-16 of its WW domain. Phosphorylation of Ser-16 or 
substitution of Ser-16 with glutamine to mimic phosphorylation abolishes Pin1’s 
ability to interact with its substrates, thereby inhibiting its physiological activities (Lu 
et al., 2002b). Interestingly, Pin1 is found to be hypophosphorylated in breast cancer, 
indicating that phosphorylation of Pin1 indeed inactivates Pin1 in vivo (Wulf et al., 
2001). However, it is still not known which kinases and phosphatases are responsible 
for this regulation in vivo, although protein kinase A has been shown to be able to 
phosphorylate Pin1 in vitro (Wulf et al., 2005). A recent study has shown that 
phosphorylation of Pin1 is reversely correlated with phosphorylated GSK3β, 
indicating that GSK3β may be responsible for Pin1 phosphorylation. This data is not 
yet conclusive and deserves further investigation (Min et al., 2005). 
 
1.7 Pin1 in pathological conditions 
Pin1-mediated conformational changes following phosphorylation can have 
profound effects on cell signaling by regulating a spectrum of target activities. Pin1 
activity, in turn, is tightly regulated by multiple mechanisms and its deregulation has 
an important role in pathological conditions.  
 
1.7.1 Cancers 
 Overexpression of Pin1 is prevalently found in many human cancers， including 
breast, prostate, cervical, brain, lung, and colon cancers (Lu, 2003). Overexpression of 
Pin1 could therefore be a primary event in human cancers. 
 26 
Table 1-1 Pin1 substrates and their regulation by Pin1. 




NIMA Mitotic kinase -- -- Genetic interaction (Lu et al., 1996b; Lu and Hunter, 1995; Ye et 
al., 1995) 
Nek6 Mitotic kinase -- -- -- (Chen et al., 2006) 
Wee1 Mitotic kinase -- -- Genetic interaction (Shen et al., 1998) 
Myt1 Mitotic kinase -- -- -- (Shen et al., 1998; Wells et al., 1999) 
Plk1 Mitotic kinase -- WW domain binds 
substrate 
-- (Eckerdt et al., 2005; Crenshaw et al., 1998; 
Shen et al., 1998) 
Raf-1 Mitotic kinase pSer29-Pro; pSer43-Pro^; 
pSer289-Pro; pSer296-Pro; 
pSer301-Pro; pSer642-Pro 
PPIase activity is required 
for the dephosphorylation 
Dephosphorylation by 
PP2A 
(Dougherty et al., 2005) 
P70/S6 
kinase 
Protein kinase -- -- -- (Yaffe et al., 1997) 
Cdc25 Mitotic phosphatase pThr48-Pro; pThr67-Pro; 
pThr138-Pro; pSer205-Pro; 
pSer285-Pro 




by PP2A, genetic 
interaction 
(Zhou et al., 2000; Stukenberg and Kirschner, 
2001) 
Btk Nonreceptor tyrosine kinase pSer115-Pro; pSer21-Pro  Dephosphorylation, 
stability 
(Yu et al., 2006) 
Cyclin D1 G1/S regulator pThr286-Pro -- Protein expression, 
promote protein stability, 
nuclear localization 
(Liou et al., 2002) 
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Cyclin E G1/S regulator Ser384^ -- Promote protein 
degradation by 26S 
proteosome-mediated 
proteolysis 
(Yeh et al., 2006) 
CENP-F Kinetochore protein -- -- -- (Shen et al., 1998) 
Incenp Inner centromere protein -- -- -- (Shen et al., 1998) 
Cdc27 Anaphase-promoting complex -- -- -- (Yaffe et al., 1997; Shen et al., 1998) 
Rab4 GTP-binding protein pSer196  Localization, 
protein-protein interaction 
(Yaffe et al., 1997; Gerez et al., 2000) 
Anti-apoptotic proteins 
Bcl-2 Anti-apoptotic protein pSer70-Pro*; pSer87-Pro*  Dephosphorylation, nuclear 
translocation 
(Basu et al., 2002; Basu and Haldar, 2002; 
Pathan et al., 2001) 
BIMEL Apoptotic protein pSer65-Pro WW domain binds 
substrate 
Promote protein stability (Becker and Bonni, 2006) 
Tis/BTG2/pc
3 
Antiproliferative protein pSer147-Pro -- -- (Hong et al., 2005) 
JIP3 Neuron-specific JNK signaling scaffold 
protein 
-- WW domain binds -- (Becker and Bonni, 2006) 
Transcription factors / Gene regulation 
 
c-Jun Transciptional activator pSer63-Pro; pSer73-Pro Both domains required for 
the activity 
Transcriptional activity (Wulf et al., 2001) 




(Ryo et al., 2001) 
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RNA Pol II Transcriptional initiator pSer5-Pro (in repeated 
sequence) 
  (Jacobs et al., 2003; Verdecia et al., 2000; Shen 
et al., 1998; Wu et al., 2000) 
NFAT Transcriptional activator pSer5-Pro (in repeated 
sequence) 
WW domain binds 
substrate 
Inhibit dephosphorylation 
by calcineurin, localization 
in cytosol 
(Liu et al., 2001) 
p53 Transcriptional activator pSer33-Pro; pSer46-Pro; 
pThr81-Pro; pSer315-Pro 
 Promote protein stability, 
transcriptional activity 
(Berger et al., 2005; Zheng et al., 2002; Zacchi 
et al., 2002; Wulf et al., 2002)  
NF-κB Transcriptional activator pThr254-Pro  Nuclear translocation, 
transcriptional activity, 
promote protein stability 
(Ryo et al., 2003) 
 
c-Myc Transcriptional activator pThr58-Pro#; pSer62-Pro WW domain binds 
substrate 
Promote degradation by 
28S proteosome, 
dephosphorytion by PP2A 
(Yeh et al., 2004) 




(Saitoh et al., 2006) 
p73 Transcriptional activator pSer412-Pro; pThr442-Pro; 
pThr482-Pro 
PPIase is required for the 




(Mantovani et al., 2004) 
c-fos Transcriptional activator pThr232-Pro#;pThr325-Pro 
pThr331-Pro; pSer374-Pro
 Transcriptional activity (Monje et al., 2005) 
SRC-3/AIB1 Transcriptional coactivator pThr24-Pro; pSer505-Pro; 
pSer543-Pro; S860-Pro; 
pSer867-Pro 





(Yi et al., 2005; Wu et al., 2004) 
Cf-2 Transcriptional repressor pThr40-P  Promote protein 
degradation, transcriptional 
activity 
(Hsu et al., 2001) 
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RARalpha Transcriptional regulator pSer77-Pro -- Promote degradation by 
26S proteosome 
(Brondani et al., 2005) 
Alzheimer’s disease related 
Tau Microtubule-binding protein pThr212-Pro; pThr231-Pro  Protein-protein interaction, 
protein dephosphorylation 
(Lu et al., 1999a; Smet et al., 2004) 
APP May involved in the survival and 
differentiation of neuronal cells 
pThr668-Pro WW domain binds  
 
(Pastorino et al., 2006) 
 
Others 
Synphilin-1 Trafficking-related protein pSer211-Pro; pSer215-Pro  Protein-protein interaction (Ryo et al., 2006) 
Lipofuscin Lysosomal accumulated granule of 
fluorescent retinoid, lipid and protein debris
-- -- -- 
 
(Hashemzadeh-Bonehi et al., 2006) 
Sin3-Rpd3 Histone deacetylase --  Genetic interaction (revalo-Rodriguez et al., 2000) 
 
p54nrb Nuclear factor pThr412-Pro; pThr430-Pro; 
pThr452-Pro 
WW domain binds -- (Proteau et al., 2005) 
NHERF-1 Na+/H+ exchanger regulatory factor pSer279-Pro; pSer301-Pro  Dephosphorylation by 
PP2A/PP1 
(He et al., 2001) 
KRMP1 Kinesin-related protein -- WW domain binds 
substrate 
-- (Kamimoto et al., 2001) 






WW domain bind substrate -- (Campaner et al., 2005) 
* no actual proof # major binding site   ^ not pSer/Thr-Pro motif 
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 Pin1 is a critical catalyst at multiple steps in oncogenic pathways. Most 
importantly, Pin1 regulates the function of Cyclin D1, an essential protein upregulated 
during breast cancer development. Pin1 stabilizes and upregulates Cyclin D1 on both 
transcriptional and post-translational levels (Wulf et al., 2005). At the transcriptional 
level, Pin1 promotes Cyclin D1 gene expression through Ras/JNK and Wnt/β-catenin 
signaling pathways to stabilize transcription factors c-Jun and β-catenin, respectively. 
Pin1 also activates and stabilizes NF-κB in response to cytokine stimulation to 
enhance the transcriptional activity of NF-κB towards Cyclin D1 gene. Moreover, 
c-Myc, which is a substrate of Pin1, upregulates Cdk4. Cdk4 in turn activates the E2F 
genes to enhance the transcriptional level of Cyclin D1 as well as of Pin1 itself. This 
positive feedback loop suggests that deregulation of Rb/E2F pathway, as seen in many 
cancers, may be a cause for the elevated Pin1 levels in many cancers. At the protein 
level, Pin1 stabilizes cyclin D1 directly by preventing its nuclear export and 
proteolysis in the cytoplasm. Hence, Pin1 raises Cyclin D1 levels, which will lead to 
cell proliferation and transformation (Figure 1-2).  
 
 Pin1 can be a cancer prognostic marker. Increased Pin1 levels are indeed highly 
predictive of cancer recurrence after prostatectomy (Wulf et al., 2005). Moreover, 
Pin1 can also be a molecular target for cancer therapies. Specific Pin1 inhibitors are 
currently being developed. Juglone is an effective Pin1 inhibitor, acting by covalently 
inactivating Cys-113 residue at the active site of Pin1. However, it also potently 
inhibits other Parvulin-type PPIases and many other proteins and enzymes. Other Pin1 
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inhibitors are designed mainly based on competitive binding, with the chemicals 
inhibiting the interaction between Pin1’s WW domain and the phosphopeptides at the 
binding surface, such as PiB and its analogs. PiB and its analogs have been shown to 
inhibit cell growth, but they inhibit non-phosphorylation-specifc prolyl isomerases 
such as Par14 as well. Thus, more specific Pin1 inhibitors needs to be developed (Lu, 
2003).  
 
Figure1-2: Roles of Pin1 in the regulation of Cyclin D1 in cell proliferation and 
oncogenesis. (Adapted from Lu (2003), Cancer Cell, 4: 175-180) 
 
1.7.2 Alzheimer’s disease 
 Pin1 is implicated in Alzheimer’s disease (AD). So far, there is no definitive 
clinical diagnosis and effective treatment available for the disease. This disease is 
clinically characterized by a progressive loss of memory, dementia and eventually 
death, with an average survival time being about ~8 years after the onset of the 
disease (Lu et al., 2003b). Its neuropathological hallmarks consist of intracellular 
neurofibrillary tangles (NFTs) and extracellular neuritic plaques, with neuronal cell 
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death in specific areas of the brain such as the hippocampus (Lu et al., 2003a).  
 
NFTs contain paired helical filaments (PHFs) composed of aggregates of 
phosphorylated and ubiquitinated Tau, which forms a β-pleated sheet structure. Tau is 
a microtubule-binding protein that promotes microtubule assembly in neurons. Under 
normal circumstances, mitotic events phosphorylate Tau and such phosphorylation 
would abolish Tau’s ability to bind microtubule for microtubule assembly, thereby 
inhibiting normal neuronal functions. However, interaction of Pin1 with Tau at its 
pThr212-Pro and pThr231-Pro motifs causes a conformational change, making Tau 
accessible to PP2A for dephosphorylation. In this way, Pin1 restores Tau’s function in 
binding to microtubules. In AD’s brains, abnormal activation of mitosis causes Tau to 
be hyperphosphorylated. Hyperphosphorylation of Tau creates excess Pin1 binding 
sites. Pin1 could thus be redirected from nucleus to the cytoplasm and trapped in the 
NFTs. Thus, functional Pin1 becomes depleted in the nucleus as well as subcellular 
compartments, which could lead to mitotic arrest and eventually neuronal cell death.  
   
AD neuritic plaques are composed of massive accumulation of amyloid β 
peptides (Aβ), derived from the amyloid precursor protein (APP). Full-length APP is a 
transmembrane protein and it undergoes sequential proteolytic cleavage by at least 
three proteases called α-, β-, and γ-secretases. α-secretase and β-secretase cleave APP 
within the extracellular domain to shed off large soluble APP derivatives called 
α-APPs and β-APPs, respectively. The remaining membrane-tethered α- or 
β-carboxy-terminal fragments (APP-CTFα and APP-CTFβ, respectively) are then 
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cleaved by γ-secretase within the transmembrane domain, producing either a 3 kDa 
product (p3 for APP-CTFα) or Aβ (for APP-CTFβ), and the APP intracellular domain 
(AICD) (Figure 1-3). Aβ has long been postulated as the primary etiology agent of 
AD. Accumulation of insoluble, extracellular Aβ forms neuritic plaques in AD’s 





Figure 1-3: Pin1 in APP processing and its role in forming amyloidogenic Aβ in 
Alzheimer’s disease. (A) APP processing; (B) Pin1’s regulation of APP processing (adapted 
from Pastorino et al. (2006), Nature, 440: 528-534). 
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 Studies by Pastorino et al. reveals that Pin1 regulates APP processing (Pastorino 
et al., 2006). Pin1 can interact with APP phosphorylated at its Thr668-Pro motif on 
the plasma membrane, thus catalyzing a conformational change of APP from cis to 
trans. Interestingly, the cis conformation of APP favors amyloidogenic APP 
processing, and the combination of β- and γ-secretase cleavage generates β-APPs and 
Aβ. The trans conformation undergo non-amyloidogenic APP processing, with the 
combination of α- and γ-secretase generating α-APPs and p3. By catalyzing the 
conformational change from cis to trans, Pin1 thus favors non-amyloidogenic APP 
processing and reduces Aβ formation (Figure 1-3). In AD’s brains, Pin1 is depleted 
and / or inhibited by oxidative damage in the neurons. Without the proper function of 
Pin1, the cis pThr668-Pro motif would not be isomerized to trans in a timely manner. 
Hence, amyloidogenic APP processing is favored leading to accumulation of secreted 
Aβ to form neuritic plaques.   
 
1.8 The structural basis of Pin1 function 
On a structural perspective, a number of crystal and NMR structures of human 
Pin1 as well as some of its homologues, together with their biochemical analyses, 
have furthered our understanding of the structure-function relationship of Pin1. 
 
1.8.1 The X-ray structure of human Pin1 
Pin1 and its homologues are characterized by an N-terminal WW domain and 
a C-terminal PPIase catalytic domain (Ranganathan et al., 1997; Zhou et al., 2000; 
Yaffe et al., 1997). The three-dimensional crystal structure of human Pin1 was first 
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determined in 1997. The WW domain of Pin1 (residues 1-39) is made up of a compact 
anti-parallel three-stranded β-sheet, while the PPIase domain (residues 45-163) folds 
into a flattened half β-barrel, which consists of a four-stranded anti-parallel β-sheet, 
surrounded by four α-helices (Figure 1-4) (Lu et al., 2002b; Ranganathan et al., 1997).  
 
In the crystal structures, the two structural domains are organized around a 
concave hydrophobic cavity and are tethered. There are three hydrophobic patches on 
the molecular surface: the concave inter-domain cavity, the catalytic site surrounding 
Cys-113, and the shallow cleft composing of Ile-96, Phe-103, Met-146, and Leu-160 
(β3 strand and helix α4). These three hydrophobic surfaces constitute a continuous 
hydrophobic patch on the Pin1 molecular surface. In NMR studies in solutions, 
interaction between the two domains was abolished when full length Pin1 is cleaved 
at the flexible linker. Hence, although a large interface has been observed in the 
crystal structures, weak interaction between the two domains has been speculated 
(Bayer et al., 2003; Jacobs et al., 2003). Through differential chemical shift mapping 
between the two domains, an inter-domain interaction surface as in the X-ray 
structures is also discernible—the hydrophobic cavity comprising the concave surface 
of the WW domain (β3’ strand, and β1’/β2’ and β2’/β3’ loops) and the shallow cleft of 




Figure 1-4: Pin1 crystal structure (PDB code: 1PIN). (Left) Cartoon representation of Pin1 
structure. (Right) Pin1 surface properties. The figure shows a colour-coded representation of 
the distribution of a calculated parameter α that describes the degree of conserved, 
solvent-exposed hydrophobicity. Α values range from 0 (white) to 1 (red), where the highest 
values are scored by identical, fully exposed hudrophobic residues. (Adopted from 
Ranganathan et al. (1997), Cell, 89(6):875-886) 
 
1.8.2 The WW domain and its ligand specificity 
In general, WW domains behave like Src homology 3 (SH3) domains as they 
recognize Pro-rich sequences. SH3 domains are modular binding domains found in 
many signaling proteins that mediate their assembly with specific proteins via binding 
to proline-rich stretches in their respective binding partners (Macias et al., 2002). 
Likewise, WW domains work as universal protein modules for binding Pro-rich 
ligands in many signaling proteins, including Nedd4, Rsp5, Smurf1, and YAP65, to 
target these to their substrates. The Pin1 WW domain is classified as a Group IV WW 
domain, which shows substrate preference towards Ser/Thr-Pro-containing peptides in 
a phosphorylation-dependent manner when assayed alone apart from PPIase domain 
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(Kato et al., 2002; Kato et al., 2004). On the other hand, mNedd4, Rsp5, Smurf1 and 
YAP65 contain the Group I WW domains, which recognizes the Pro-Pro-Xaa-Tyr (PY 
motif, Xaa denotes any amino acid), and the reported NMR structure of the isolated 
YAP65 WW domain exhibits a similar fold with Pin1 WW domain (Ranganathan et 
al., 1997). This indicates that WW domains are well conserved. Several groups, 
through mutational studies, have shown that the Pin1 WW domain is critical for its 
substrate recognition by acting as a pSer-Pro or pThr-Pro binding module. For 
example, mutation at Pin1 catalytic site diminishes its PPIase activity but its binding 
affinity towards its substrate is not compromised (Shen et al., 1998). The WW 
domains of both human Pin1 and its yeast homologue Ptf1/Ess1 are indispensable for 
function. Under normal expression conditions, both domains are required to rescue 
the yeast ptf1/ess1 mutant. However, when overexpressed, only the PPIase domain, 
but not the WW domain, can rescue the lethality of Ptf1/Ess1 deletion (Lu et al., 
1999b; Lu et al., 2002a; Zhou et al., 2000). Thus, these observations provided 
evidence that the WW domain confers substrate specificity and target Pin1 to its 
substrates, whereas the PPIase domain is both sufficient and necessary to induce the 
conformational changes and to carry out the essential catalytic function of the enzyme. 
Interestingly, the plant Pin1 homologue, Pin1at, lacks an N-terminal WW domain but 
still exhibits specific pSer/Thr prolyl cis/trans isomerase activity (Landrieu et al., 
2002). 
  
 It remains as a challenge to identify a consensus sequence recognized by Pin1. 
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However, in general, Pin1 prefers a pSer/Thr-Pro motif that is surrounded by multiple 
upstream hydrophobic residues such as leucine, isoleucine, valine, tyrosine and/or 
phenylalanine, and a downstream arginine or lysine residue (see Table 1-2) (Lu et al., 
1999b; Yaffe et al., 1997; Wulf et al., 2005). 
 
Table 1-2: Pin1 substrate sequences. 









Cdc25 Thr48-Pro, Thr67-Pro SVTFSPEQPLTPVTDLAVGFSNLSTFSGETPKRCLDLSNL 
Cyclin D1 Thr286-Pro EVEEEAGLACTPTDVRDVDI 
p53 Ser33-Pro, Ser46-Pro WKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTE 
Tau Thr212-Pro, Thr231-Pro SPGTPGSRSRTPSLPTPPTREPKKVAVVRTPPKSPSSAKS 
c-Jun Ser63-Pro, Ser73-Pro LRAKNSDLLTSPDVGLLKLASPELERLIIQS 
CTD Repeated sequence YSPTSPSYSPTSPSYSPTSPS 
c-Myc Thr58-Pro SEDIWKKFELLPTPPLSPSRRSGLCSPSYVAVTP 
RARalpha Ser77-Pro EEIVPSPPSPPPLPRIYKPCFV 
Tis21 Ser147-Pro QVLLGRSSPSKNYVMAVSS 
NFκB p65/RelA  Thr254-Pro HRQVAIVFRTPPYADPSLQAPVRVSM 
Cyclin E * Ser384 ASPLPSGLLTPPQSGKKQSS 
* denotes non pSer/Thr-Pro motif  
 
The function of Pin1 WW domain in targeting Pin1 to its substrates is further 
supported by structural analyses of Pin1 and its WW domain complexed with peptides. 
In these studies, the pSer/Thr-Pro peptides bound to the WW domain in the trans 
conformation, with multiple sequence-specific interactions contributing to the binding 
specificity. Pin1 structure complex with a doubly phosphorylated peptide 
(Tyr-pSer2’-Pro-Thr-pSer5’-Pro-Ser) derived from the C-terminal repeated domain 
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(CTD) of RNA polymerase II reveals a concave binding site in the WW domain, 
comprising of Phe-25, Arg-14, Ser-16, Arg-17, Tyr-23, and Trp-34 (see Figure 1-5) 
(Verdecia et al., 2000). Solution NMR studies of Pin1 WW domain complexed with 
another two monophosphate peptide substrates derived from Xenopus laevis Cdc25 
(Glu-Gln-Pro-Leu-pThr-Pro-Val-Thr-Asp-Leu) and from human tau protein 
(Lys-Val-Ser-Val-Val-Arg-pThr-Pro-Pro-Lys-Ser-Pro-Ser), respectively, reveal the 
same extended binding site around residues Ser-16, Arg-17, Tyr-23, and Trp-34 
(Wintjens et al., 2001). The Pin1-CTD complex structure displays two positively 
charged residues which may be important for the phosphopeptide binding, namely 
Arg-14 and Arg-17. Arg-14 recognizes Pro-3’of the ligand peptide, whereas Arg-17 
interacts with the phosphate group of pSer-5’. These two arginine residues on the 
ligand-binding site may therefore determine the ligand specificity of Pin1 WW 
domains. However, some WW domains of Pin1 homologues, such as Aspergillus 
nidulans PinA and Neurospora crassa SspI, do not have residues at position 
equivalent to Arg-17, but residue Arg-14 is conserved in these two homologues. When 
compared across the subfamilies in WW domain family, Group I WW domains of 
mNedd4, Rsp5 also has a conserve Arg-14 but dystrophin and hYAP65 do not. 
Moreover, between these two subgroups of Group I WW domain, there is little 
relationship between charge distribution and ligand specificity. This suggests that the 
residue Arg-14 in Pin1 may not be important for its substrate specificity in 
pSer/Thr-Pro motifs binding. Indeed, mutation studies also verified that Arg-14 is less 
critical for peptide binding than residues Ser-16, Arg-17, Tyr-23, and Trp-34, which 
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also reside at the binding interface of Pin1 with CTD peptide (Verdecia et al., 2000; 
Kato et al., 2002).  
 
 Structures of several Proline-rich sequence binding modules, analyzed together 
with Pin1 WW domains, have revealed a model of Pin1 substrate recognition 
specificity. In the surface of SH3 and WW domain of both dystrophin and Pin1, a 
series of parallel aromatic residues comprise a groove against which polyproline II 
(PPII) helix formed by proline-rich sequences packs. These grooves recognize a pair 
of residues of the sequence Xaa-Pro (where Xaa is any amino acid). In SH3 domains, 
two successive X-P grooves are formed by the conserved Trp, Tyr, and Phe residues to 
recognize the consensus sequence Xaa-Pro-Xaa-Pro-Xaa in proline-rich sequences. 
However, there is only a single X-P groove in Group I and IV WW domains formed 
by the conserved Tyr and Trp residues to recognize the Pro-Pro-Xaa-Tyr and 
pSer/Thr-Pro motifs. Hence, such an X-P groove confers the proline binding 
specificity (Zarrinpar and Lim, 2000).  
 
On the other hand, individual binding module exhibits sequence specificity 
conferred by the variable loops and neighboring domains. In WW domains, sequences 
between β1’ and β2’, and between β2’ and β3’ are called loop I and loop II, 
respectively. Loop I directly abuts on the X-P groove whereas loop II lies at the 
opposite end of the interaction surface. In Group I WW domains, such as dystrophin 
and mNedd4, loop II forms a hydrophobic pocket, and Tyr residue within the 




















Figure 1-5. Substrate binding of Pin1.  (A) Schematic presentation of Pin1 WW domain in 
complex with the doubly phosphorylated CTD peptide (Tyr-pSer2’-Pro-Thr-pSer5’-Pro-Ser) 
(adapted from Verdecia et al. (2000), Nat. Struct. Biol., 7: 639-643). (B) Peptide binding 
orientation to Pin1 and dystrophin WW domain, and SH3 (adapted from Zarrinpar (2000), 
Nat. Struct. Biol., 7: 611-613). (C) Surface depiction of the Pin1 and dystrophin WW domain 
in complex with peptides. X-P binding groove (white box) is flanked by multiple specificity 
elements, including residues in loop I (purple), residues in loop II (orange), and neighbouring 
domains (lavender).  
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Tyr binding loop, and it is responsible for the substrate specificity of Group I WW 
domain. In contrast, loop I accounts for the determination of substrate specificity of 
Group IV WW domains (Zarrinpar and Lim, 2000; Kato et al., 2002; Kato et al., 
2004). As observed in the structure of Pin1 WW domain complexed with CTD 
phosphopeptide, pSer5’ in the pSer-Pro motif was accommodated into loop I 
specifically and avidly in contact with the backbone amide of Arg-17, and with the 
side chain of Ser-16, Arg-17, and Tyr-23. The most energetically favoured interaction 
in this contact being the electrostatic interaction between the pSer5’ and the side chain 
ε-guanido group of Arg-17. Hence, Arg-17 is indeed important in substrate 
recognition, although it is not conserved in all the Pin1 homologues. In PinA and SspI, 
Arg-17 is replaced with Asn or Gln, respectively. According to modeled structures, 
Asn/Gln-17 can form hydrogen bonds with pSer5’. Moreover, Lys-19 can also 
contribute to the substrate binding through an electrostatic interaction, compensating 
for the absence of Arg-17. Arg/Asn/Gln-17 seems to be an extra insertion to the loop I 
region when compared to the Group I WW domain. Hence, recognition of 
pSer/Thr-Pro motifs is unique to the Group IV WW domains and loop I (or called 
p-patch) plays a key role in Pin1’s substrate specificity (Kato et al., 2002).  
 
Neighboring domains of WW domains may confer substrate specificity too. 
Evidence is seen when dystrophin WW domain alone cannot bind the dystroglycan 
ligand. An adjacent EF domain is essential in binding, with at least half of the ligand 
sequence entering into close interaction (Huang et al., 2000; Zarrinpar and Lim, 2000). 
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Likewise, in Pin1, the adjacent PPIase domain may also contribute to the substrate 
binding and specificity. However, the evidence is not conclusive. In the Pin1-CTD 
crystal structure, peptide binding is mainly contributed by the residues on the concave 
surface of the WW domain (Phe-25, Arg-14, Ser-32, Ser-16, Arg-17, Tyr-23, Trp-34), 
but not the PPIase domain, although the peptide is apparently in significant contact 
with the latter. Site-directed mutagenesis experiments demonstrate that Pin1 binds 
phosphoproteins mainly through its WW domain and that the interaction is mainly 
contributed by the aromatic rings of Tyr-23 and Trp-34. Studies with WW or PPIase 
domain alone showed that the Pin1 WW domain can bind to the peptides derived from 
Pin1’s substrates but Pin1 PPIase domain binds either weakly or not at all (Verdecia et 
al., 2000; Lu et al., 1999b). PPIase is therefore apparently not responsible for 
substrate binding. Yet, in most cases, the binding of the WW domain is enhanced by a 
factor of 1.5-2 in the presence of the PPIase domain (Verdecia et al., 2000). More 
studies are needed to investigate the role of PPIase domain in substrate specificity and 
binding. 
 
CTD, Cdc25, and tau are the peptides studied so far for Pin1 binding on a 
structural basis. All three peptides bind to the Pin1 WW domain in the same 
orientation from the N- to the C-terminal, as shown in Figure 1-5. A reverse peptide 
orientation will not fit into the binding surface. Interestingly, the β-dystroglycan 
peptide binding to dystrophin WW domain adopts a reversed peptide binding 
orientation compared to that of the Pin1 WW domain, whereas the SH3 domain could 
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bind to its peptide substrates in either orientation (Huang et al., 2000; Zarrinpar and 
Lim, 2000). Thus, substrate specificity again arises, with different orientation 
requirement for the different peptide sequences. Furthermore, the pThr-Pro peptide 
bonds in the three peptide ligands bound to Pin1 WW domain are in the trans 
conformation. This is consistent with the functional studies of Cdc25 and Tau, where 
Pin1 catalyzes their conformational change from cis to trans, makes them substrates 
for PP2A and/or PP1 dephosphorylation. PP2A is known to dephosphorylate only the 
trans pSer/Thr-Pro motif. Furthermore, in studies with APP peptide using NMR, it 
was revealed that Pin1 binds to both cis and trans conformations with comparable 
affinity although Pin1 catalyzes the cis to trans conformational switch. Thus, it has 
been proposed that Pin1 WW domain binding to either cis or trans conformation is 
sequence-specific (Pastorino et al., 2006). Moreover, it is the intrinsic catalytic 
mechanism of Pin1, rather than binding affinity, that routes its isomerization activity 
from cis to trans conformation.  
 
Together, these studies suggest a unique binding scheme for the Pin1 WW 
domain to multiple substrates, although more Pin1 structures complexed with other 
substrates are useful to further validate this rather unique binding scheme.  
 
1.8.3 The PPIase domain’s catalytic mechanism and substrate specificity 
The Pin1 PPIase domain catalyzes peptidyl-prolyl isomerization in the 
pSer/Thr-Pro motifs between the cis and trans conformations. Such a conformational 
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change is often demonstrated using biochemical assays, such as by a shift in 
recognition by the conformation specific MPM-2 antibody and susceptibility to the 
protease chymotrypsin. Moreover, such a conformation change has been visualized at 
atomic resolution, as shown by Pastorino et al. using NMR spectroscopy (Pastorino et 
al., 2006). In this study, APP-derived phosphopeptide exhibited two distinct sets of 1H 
peaks, each corresponding to cis and trans conformations, respectively. The set of 
diagonal peaks would diminish and another set of exchange peaks would grow over 
the incubation time upon the addition of catalytic amounts of Pin1. However, the 
exchange peaks were absent when either no Pin1 or a catalytically inactive Pin1 
mutant was added. Thus, Pin1 indeed causes a conformational change in the 
phosphopeptide.  
 
1.8.3.1 Pin1 PPIase structure in comparison with FKBP 
Despite a lack of primary sequence similarity, the core β sheet and the α4 helix of 
Pin1 PPIase domain fold in a globally similar fashion to FKBP-like PPIases, in spite 
of some structural deviations between the two families. On one hand, this indicates 
that this structural motif is well conserved; on the other hand, the structural deviations 
explain the different substrate specificity and catalytic mechanisms between these two 
families of PPIases. The main deviation comes from the segment linking β1 and β2. In 
Pin1, this segment is comprised of the β1/α1 loop, α1, the α1/α2 loop, α2, the α2/α3 
loop, and α3. However, in FKBP, the corresponding region is considerably shorter, 
spanning a total of 12 residues that form an additional β strand. This deviation from 
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FKBP has conferred Pin1-type PPIases the unique organization of their catalytic site 
with the substrate specificity towards pSer/Thr-Pro bonds. In this structural inclusion 
that is unique to the Pin1 subfamily, the α1 helix provides much of the composite 
hydrophobic surface shared with the WW domain and the residues from the α1/α2 
loop and α2 comprise part of the conserved second polyethylene glycol (PEG) 
binding site. Most importantly, the catalytic site with the multivalent anion binding 
site consisting of Lys-63, Arg-68, and Arg-69, and the active site Cys-113 crucial for 
efficient catalysis in Pin1, reside in this region as well.  
  
In the crystal structure solved by Ranganathan et al. (Ranganathan et al., 1997), a 
dipeptide of Ala-Pro and a sulphate ion are sequestered to the catalytic site. The 
sulphate ion in close proximity to the β-methyl group of the alanine residue in the 
dipeptide is sequestered to the basic patch formed by the side chains of conserved 
Lys-63, Arg-68 and Arg-69 residues, whereas the proline residue is held by a 
hydrophobic pocket formed by Leu-122, Met-130, and Phe-134 at the catalytic site. 
Thus at the structural bases, these positions suggested that a pSer/Thr-Pro motif is a 
preferred substrate for Pin1. The pSer/Thr and proline anchor to the basic patch and 
the hydrophobic binding pocket, respectively, thus orientating the peptidyl-prolyl 
bond undergoing catalyzed cis/trans isomerization near the active site Cys-113 and to 
be surrounded by the side chains of Cys-113, His-59, His-157, and Ser-154. Hence, 
the basic patch serves as a selectivity filter to confer Pin1 phosphorylation specificity, 
whereas the active site grants efficient peptidyl-prolyl cis/trans isomerization. 
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Mutation studies support this notion, in which Arg-68 and Arg-69 completely 
abolishes the phosphorylation-specificity but has little effect on the basic enzymatic 
activity. Moreover, Cys-113, His-59, His-157, and Ser-154 are absolutely conserved 
in Pin1 homologues, while the basic patch is present merely in Pin1 homologues, and 
not in any other known PPIases. In FKBP, instead of a basic patch, hydrophobic 
residues Ile-90, Ile-91, and Phe-36 are found at a spatially analogous position. This 
observation has explained its preference for hydrophobic residues N-terminal to 
proline in its peptide substrates. On the other hand, there isn’t any analogous 
structural motif in cyclophilin, explaining the lack of any specificity at a residue 
N-terminal to proline when acting upon tetrapeptide substrates by the cyclophilin 
family of PPIases (Harrison and Stein, 1990). Hence, the basic patch in Pin1 is indeed 
a signature patch of the Pin1-type PPIases that is critical for the substrate selection. 
Taken together, these observations imply the unique and conserved catalytic 
specificity, and mechanism of function of Pin1 in various species.  
 
1.8.3.2 Proposed catalytic mechanism of Pin1  
Two catalytic models for Pin1 have been proposed. In the first model, a covalent 
catalytic mechanism of peptidyl-prolyl isomerization unique to Pin1-type of PPIases 
has been elaborated based on the spatial arrangement of Cys-113, His-59, His-157, 
and Ser-154 relative to the isomerized peptide bond, and according to the crystal 
structure of Pin1 in complex with Ala-Pro dipeptide (PDB code: 1PIN) (Ranganathan 
et al., 1997). In this model, the first step involves a partial bond rotation by the 
 48
favorable energetic forces (substrate in cis configuration). A proton from Cys-113 is 
then extracted by the deprotonated imidazole nitrogen of His-59, followed by a 
nucleophilic attack on the carbonyl carbon of the substrate’s peptide bond by the 
newly formed thiolate side chain (step 2), thus leading to the formation of a 
high-energy covalent tetrahedral intermediate between the substrate and enzyme (step 
3). The resulting negative charge on the former carbonyl oxygen is then stabilized 
through electrostatic interactions with a protonated His-157 (step 3). This high-energy 
intermediate then relaxes back to either cis or trans ground states of the peptide bond 
(stage 1 or 4, respectively) (Figure 1-6) (Ranganathan et al., 1997). 
 
In contrast to other PPIase structural classes, Pin1 appears to exhibit the 
additional properties of covalent catalysis. The catalytic model, with catalysis 
occurring through the summed energetic contributions of distinct structural units, is 
supported by several lines of evidence (Ranganathan et al., 1997). Firstly, Pin1 indeed 
demonstrates a proton concentration dependency with a bell-shaped titration curve, 
with its activity increasing from zero to maximal with an apparent pKa of 7.5. This is 
consistent with the reaction scheme which implies pH sensitivity of Pin1 activity, as 
seen in the deprotonation of His-59 and the protonation of His-157. Moreover, the 
calculated pKa is well within the expected range for neighboring histidines in a 
protein environment (Ranganathan et al., 1997). Second, mutation of Cys-113 to 
alanine or serine resulted in a decrease in Pin1 catalytic activity with a 123-fold or 
20-fold decrease in Kcat/Km, respectively (Ranganathan et al., 1997). Finally, a Pin1 
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triple mutant, G155A-H157A-I159A, failed to complement the yeast ess1- mutation in 
vivo and lacked a detectable PPIase activity against the standard PPIase substrate, 
succinyl-AlaAlaProPhe-pNA, in vitro. This has supported a role for His-157 in the 




Figure 1-6: Proposed covalent catalytic mechanism of Pin1-nucleophilic catalysis model. 
(Adopted from Ranganathan et al. (1997), Cell, 89(6): 875-886) 
 
 Based on the first model of nucleophilic attack, replacement of residue Cys-113 
with negatively charged residue Asp should result in a much poorer nucleophile. 
However, mutant C113D did not experience significant loss in Pin1 function. Hence, 
a second model of non-covalent catalytic mechanism has been proposed, as is the case 
with other peptidyl-prolyl isomerases (Behrsin et al., 2006). In this second model, the 
local environment around Cys-113, particularly Ser-111, Ser-115 and water-1005 
(from PDB code 1PIN) would maintain Cys-113 in a state such that it would present a 
partial or full negative charge to the carbonyl oxygen atom of the substrate when it is 
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bound initially in the cis conformation. The negative charge in the immediate 
environment of the carbonyl oxygen would weaken the double bond character of the 
substrate pSer-Pro peptide bond, allowing a rotation from the cis towards the 
transition state for catalysis (Behrsin et al., 2006).  
 
1.8.4 Dynamic interactions between Pin1 WW and PPIase domains 
From the crystal structures, Pin1 WW domain and PPIase domain appeared to 
exhibit rigid interaction with other. In contrast, weak interaction between the two 
functional domains is observed by NMR studies in solution. When full length Pin1 is 
dissected into two separate domains through the flexible linker, the interaction 
between the two domains is abolished (Bayer et al., 2003; Jacobs et al., 2003). Since 
NMR reflects the properties of molecules in solution, it may be a better indication of 
the native state of Pin1 in solution.  
 
It is important to further understand how the two flexible domains work with each 
other to achieve Pin1 specificity and cis/trans isomerization of substrate proteins. 
Jacobs et al. (Jacobs et al., 2003), through several NMR methods, had observed an 
enhancement of inter-domain interactions upon peptide binding, although there are no 
substantial conformational changes in the small and compact structures of both 
functional domains. In the context of Pin1’s interaction with Cdc25 
(EQPLpTPVTDL), CTD (YpSPTpSPS), and Pintide (WFYpSPR), inter-domain 
flexibility is reduced upon peptide binding in their trans conformation in the order of 
Cdc25 < CTD < Pintide (i.e. with Pintide most significantly restricts the flexibility of 
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the two domains). In another words, interaction between the WW and PPIase domains 
is most enhanced upon Pintide binding. Compared to the other two peptides, Pintide 
has the highest N-terminal hydrophobicity. This N-terminal hydrophobicity preference 
suits the N to C peptide binding orientation (as described earlier) well, in which the 
hydrophobic N-terminus is orientated toward the hydrophobic parts of the 
inter-domain interaction surface. Note that Pintide is the optimal sequence selected 
from a peptide scan and which binds to Pin1 with the highest affinity. These 
observations implied that the two functional domains may indeed interact upon 
preferable peptide binding. Meanwhile, it is also possible that the two domains 
interact to form a floppy hydrophobic cleft which accommodates molecules of a 
limited size upon peptide binding, and larger peptides may disrupt such inter-domain 
interactions. The sizes for Cdc25, CTD, and Pintide are 10mers, 7mers, and 6mers, 
respectively, and it cannot be excluded that the observed trend of inter-domain 
interactions is predominantly a steric hindrance effect.  Moreover, in considering that 
short peptides may not exploit the complete binding site, it remains speculative to 
what extent the findings are applicable to Pin1 full-length substrates. Nevertheless, 
these studies have shed some light on the possible substrate specificity and 
mechanism of Pin1 function. 
 
 It is noteworthy that the Pin1 homologue in Candida albicans, Ca-Ess1, exhibits 
a rigid juxtaposition of the WW and PPIase domains, with an orientation that is 
different from that observed in human Pin1 (Figure 1-7) (Li et al., 2005). Moreover, 
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the two functional domains are believed to be fixed in a more permanent functional 
conformation, in contrast to the domain flexibility observed for human Pin1. These 
attributes are mainly contributed by a linker which is 11 residues longer than that of 
human Pin1, and the extensive interaction between the two functional domains and 
the linker. The linker contains a long α-helix which is highly structured. This helix 
and its interaction with nearby residues are believed to constrain the WW domain 
against the PPIase catalytic domain. Extensive interaction was observed between the 
N-terminal β1 of the WW domain and the loop connecting α5 (corresponds to α4 of 
Pin1) and β6 of the PPIase domain, and between the loops linking β2 and β3 of the 
WW domain and the C-terminus of α2 of the PPIase domain. Moreover, through such 
an extensive inter-domain interaction, the hydrophobic pocket between the domains 
that was implicated as the substrate binding site is eliminated. Thus, these differences 
suggest different mechanisms of substrate interaction and catalysis among the Pin1 
homologues (Table 1-3).  
 
Some Pin1 homologues such as the homologues in bacteria and plants do not 
have the WW domains at the N-terminus, although these too have the same specificity 
for pSer/Thr-Pro motifs. NMR studies revealed that the Arabidopsis thaliana Pin1 
homologue, At-Pin1at, has a similar overall folded structure with Pin1’s PPIase 
domain, except that it has an additional 19-residue flexible loop between β1 and α1  
(Figure 1-7) (Landrieu et al., 2002). Its interaction site with phosphor-Cdc25 peptide 
was mapped in the loops between α4 and β3, between β3 and β4, in α3, and in 
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theβ1/α1 loop. The Arg-21 and Arg-22 residues which are located in the β1/α1 loop 
are analogous to Arg-68 and Arg-69 in the human Pin1, which is responsible for the 
substrate specificity. Besides these two acidic residues which are unique among the 
plant Pin1 homologues, no other structural elements likely to participate in substrate 
binding are known. Metzner et al. (Landrieu et al., 2002; Metzner et al., 2001) had 
proposed that another Pin1 homologue in plant, DIPar13, apparently overcomes the 
absence of the WW domain by improving the substrate affinity, based on its higher 
Kcat/Km compared to human Pin1.  
 
 
Figure 1-7: Structural comparison of human Pin1 (left), Ca-ESS1 (middle) and 
At-Pin1at (right). Pin1 homologue in Candida albicans, Ca-ESS1 (PDB code: 1YW5), has 
an extra linker (α1) which is 11 residues longer than that of human Pin1 (PDB code: 1PIN). 
While Pin1’s WW and PPIase domains are loosely interact with each other in solution, 
functional domains of Ca-ESS1 have a rigid interaction, contributed by extensive interaction 
between the N-terminal β1 and the α5/β6 loop, and between the β2/β3 loop and the 
C-terminal α2 (as indicated as arrows). These interactions abolish the hydrophobic pocket 
between WW and PPIase domains compared to human Pin1. Pin1 homologue in Arabidopsis 
thaliana, At-Pin1at (PDB code: 1J6Y), has an identical PPIase domain with human Pin1 






Table 1-3: Pin1 homologue abbreviations and their functional domains. 
Sequence Origin Functional 
Domains 
Reference 
h-Pin1 Homo sapiens WW, Rotamase (Maleszka et al., 
1996) 
m-Pin1 Mus musculus WW, Rotamase (Fujimori et al., 
1999) 
x-Pin1 Xenopus laevis 
Animal 
WW, Rotamase (Winkler et al., 2000)
Dm-dodo Drosophila melanogaster Fruit 
Fly 
WW, Rotamase (Maleszka et al., 
1996) 
Nc-ssp1 Neurospora crassa WW, Rotamase (Kops et al., 1998) 
Ca-Ess1 Candida albicans WW, Rotamase (Li et al., 2005) 
En-Pin1 Emerucella nidulans WW, Rotamase (Crenshaw et al., 
1998) 
Cn-ESS1/PTF1 Cryptococcus neoformans 
var. neoformans  
Fungi 
WW, Rotamase Unpublished 
Md-Pin1 Malus×domestica (cultivated 
apple) 
Rotamase Unpublished 
At-Pin1at Arabidopsis thaliana  
(thale cress) 
Rotamase (Landrieu et al., 
2002) 
Dl-DlPar13 Digitalis lanata 
Plant 
Rotamase (Metzner et al., 2001)
Sc-ESS1/PTF1 Saccharomyces cerevisiae WW, Rotamase (Hani et al., 1995) 
Pin1p Schizosaccharomyces pombe
Yeast 
WW, Rotamase (Huang et al., 2001) 
Ec-Parv Escherichia coli Bacteria Rotamase (Rahfeld et al., 
1994a) 
 
1.8.5 Pin1’s mechanism of action 
The current understanding on Pin1’s mechanism of action is as follows. Although 
the trans conformation is favorably generated by protein kinases in response to 
growth factor stimulation (Brown et al., 1999; Weiwad et al., 2000), the actual 
conformation adapted (either cis or trans) depends on individual pSer/Thr-Pro motifs 
with their surrounding residues in a native protein. This is influenced by the local 
structural constraints after phosphorylation, such as hydrogen-bond formation, which 
might lock certain pSer/Thr-Pro motifs in the cis conformation (Wulf et al., 2005). 
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These structural constraints determine which direction Pin1 tilts the dynamic 
equilibrium between cis and trans isomers to significantly affect the local (or even the 
global) tertiary structure of the specific target protein, thus regulating their biological 
functions. For example, under the condition in which the peptidyl-prolyl bond is 
locked in a cis conformation, Pin1 may be needed to catalyze the cis to trans 
conversion for subsequent post-translational modifications. Indeed, proteases such as 
trypsin and chymotrypsin can cleave their target peptide bonds only when the proline 
is in the trans conformation. Phosphatases such as PP2A dephosphorylate only the 
trans pSer/Thr-Pro motifs, and Pin1-dependent prolyl isomerization promotes  the 
dephosphorylation of a large number of proteins including Cdc25, Tau, c-Myc, and 
Raf-1 (Dougherty et al., 2005; Lu et al., 1999a; Zhou et al., 2000; Yeh et al., 2004; 
Stukenberg and Kirschner, 2001; Smet et al., 2004). Moreover, recent X-ray structural 
studies reveal that the F-box proteins, which target ubiquitin-mediated proteolysis in a 
phosphorylation-dependent manner, target specific pSer/Thr-Pro motifs in the trans 
conformation only (Wulf et al., 2005; Orlicky et al., 2003). This may explain the role 
of Pin1 in promoting protein turnover in the cases of Btk, Cyclin E, c-Myc, SRC-3, 
Cf-2, and RARalpha. On the other hand, when there is no local structural constraint, 
Pin1 may bind to specific trans pSer/Thr-Pro motifs and catalyzes its conversion to 
cis conformation. Thus, the resulting cis conformation is protected from 
dephosphorylation and ubiquitin-mediated proteolysis. This may explain the case of 
NFAT in which active Pin1 inhibits its dephosphorylation by calcineurin, although it 
is not yet known whether the action of calcineurin is conformation-specific. In the 
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cases of Cyclin D1, p53, IRF3, p73, BIMEL, and β-catenin, the presence of Pin1 
promotes protein stability. Pin1 might also use similar mechanisms to prevent Pin1 
substrates from being inhibited and translocated to another subcellular compartment 
as in the case of the interaction between β-catenin and APC, p53 and Mdm2, and 
NFκB and IκB (Wulf et al., 2005).  
 
1.8.6 Proposed regulatory mechanism models of Pin1 
As reviewed above, structural studies have shown that both the two functional 
domains of Pin1 exhibit peptide binding sites with a specificity for pSer/Thr-Pro 
motifs in phosphopeptides. However, it remains unclear as to exactly how the two 
domains, respectively, bind to and isomerize the substrates. There is indirect evidence 
showing that these domains might act in close temporal order on the same pSer-Pro 
motif. For example, the optimal binding peptide, Pintide, binds both WW domain and 
PPIase domain with high affinity, with dissociation constants (Kd) of 1.2 μM and 11.0 
μM, respectively. It is also the best available substrate for the PPIase activity of Pin1 
(Yaffe et al., 1997; Schutkowski et al., 1998; Lu et al., 1999b). Moreover, WW 
domain binding site appears crucial for regulating the phosphorylation site, and 
mutating them abolishes the effects of Pin1 on its substrates. However, the possibility 
of the two domains acting on separate pSer-Pro motifs cannot be excluded. In the case 
of c-Myc, Pin1 has been shown to bind to one pThr-Pro motif while promoting 
dephosphorylation of another motif in the same protein.  Indeed, many Pin1 
substrates have multiple Pin1 binding sites, such as Cdc25, p73, β-catenin, p53, Tau, 
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c-Jun, and CTD. It remains to be determined how these multiple Pin1 binding sites 
relate themselves to the Pin1 catalytic action. On the other hand, many other Pin1 
substrates have only one recognized pSer/Thr-Pro motif. In the early scenario, the 
WW domain has to dissociate from, before the catalytic domain engages and 
isomerizes, the same pSer/Thr-Pro. Alternatively the catalytic domain could act on 
another pSer/Thr-Pro in the same protein molecule. It may be informative to consider 
the continuous hydrophobic path on the Pin1 molecular surface constituted with the 
two peptide binding sites at WW and PPIase domains and the hydrophobic path on the 
backside of Pin1. This suggests that Pin1 may interact with its substrates using an 
extended recognition surface (Ranganathan et al., 1997). Thus, structural studies with 
longer substrate peptides will be needed to further delineate Pin1’s mechanism of 
action.  
 
Despite the limitations of the current knowledge, several models of how Pin1 
regulates the activities of mitotic phosphoproteins have been proposed. In all of the 
proposed models, phosphorylation of the Ser/Thr-Pro motif is a prerequisite for Pin1 
targeting and cis/trans isomerization. The first model is the sequential action model, 
in which the WW domain first targets the pSer/Thr-Pro motif and the PPIase domain 
catalyzes the cis/trans isomerization of the peptidyl prolyl bond of the same 
pSer/Thr-Pro motif (Jacobs et al., 2003; Zhou et al., 1999; Wintjens et al., 2001). 
These two events can occur sequentially and independently, and thus the inter-domain 
flexibility is not crucial. This proposal is supported by the findings that at high 
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cellular concentrations, the Pin1 PPIase domain is itself sufficient to carry out the 
essential function of Pin1 (Zhou et al., 2000). The Pin1 WW domain may specifically 
target trans pSer/Thr-Pro motifs, and in doing so increase the local concentration of 
the target. Full-length Pin1 therefore gives higher catalytic activity compared to the 
PPIase domain alone. In another scenario, the catalytic domain could induce a 
conformational transition from cis to trans of the pSer/Thr-Pro motif prior to WW 
domain binding. Before a return to the cis/trans equilibrium state, the WW domain 
could then immediately engage the pSer/Thr in the trans conformation, thereby 
stabilizing this conformation and simultaneously increasing the local concentration of 
Pin1. For substrates with repetitive targeting motifs such as Cdc25, Tau, and CTD, 
initial binding and isomerization may trigger a succession of alternating binding and 
isomerization, each one revealing a further site to be isomerized. Thus, Pin1 “jumps” 
from one motif to another. Moreover, in this model, inter-domain contacts may serve 
as an extended recognition surface to control the accessibility of different substrates. 
However, two functionally separate domains are not mandatory for this sequential 
model, because the WW domain needs to dissociate in order for the PPIase domain to 
then bind and isomerize the pSer/Thr-Pro peptide substrate. 
 
The second model is “tag and twist” model in which kinases “tag” the substrates 
via phosphorylation and Pin1 subsequently isomerizes (“twist”) the pSer/Thr-Pro 
imide bond, and in this model inter-domain flexibility is crucial (Jacobs et al., 2003; 
Lu et al., 2002a; Wintjens et al., 2001). For substrates with repetitive targeting motifs, 
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the WW domain could target Pin1 to the specific pSer/Thr-Pro motifs, followed by 
isomerization of neighbouring pSer/Thr-Pro amide bonds through the PPIase domain. 
In another scenario in which Pin1 functions in a multienzyme complex with a kinase 
or phosphatase, Pin1 is recruited to the multienzyme complex through its WW domain 
interacting with a pSer/Thr-Pro motif, and PPIase domains isomerizes a pSer/Thr-Pro 
on another protein in the complex. For CTD, which exists in a dynamic equilibrium 
between hypophosphorylated and hyperphosphoryated forms resulting from 
antagonistic actions of specific kinases and phosphatases, this model suits well. Pin1 
WW domain may also bind to phosphorylated Plk I to provide a complex that first 
phosphorylates Cdc25 and subsequently activates this substrate by cis/trans 
isomerization (Jacobs et al., 2003). Indeed, many kinases and phosphatases have 
pSer/Thr-Pro motifs themselves. In view of the substrate diversity of Pin1, Pin1 can 
be recruited and catalytically active in multitude different target protein complexes 
only when its inter-domain interaction is very flexible. As reported by Jacobs et al. 
(Jacobs et al., 2003), Pin1 alone in solution tends towards a state with non-interacting 
domains. Upon addition of substrates, the equilibrium is shifted towards the 
complexed form of Pin1, with the two domains interacting with each other. Pin1 could 
thus fit into multienzyme complexes to isomerize and active its substrates. These 
scenarios could also explain the higher catalytic activity of full-length Pin1 in 
comparison with Pin1 PPIase domain alone. 
 
The third model is “induced-fit” model which is based on the two crystal 
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structures of Pin1 (Ranganathan et al., 1997; Verdecia et al., 2000), involving the 
opened and closed conformations at the α1/β1 loop with a tripartite basic cluster 
(Lys-63, Arg-68, and Arg-69). With no peptide binding, Arg-68 and Arg-69, which 
confer preferential binding of phosphorylated substrates to the Pin1 PPIase domain, 
reside outside of the proline ring binding pocket, adopting an opened conformation. 
Upon Ala-Pro dipeptide binding, these residues cluster in the lower portion of the 
active site Cys-113, changing Pin1 into its closed conformation. Hence the orientation 
of the α1/β1 loop might serve as an additional substrate selectivity filter in addition to 
the substrate preference of anionic charge at peptide N-terminus as conferred by the 
tripartite basic cluster. In contrast, Pin1 structure in solution appears to demonstrate 
that no such structural rearrangement occurs and the loop is in its closed conformation 
under both conditions. Furthermore, based on the structure of Pin1 homologue in 
Candida albicans Ca-Ess1, the conformation of this loop resembles the closed 
conformation, despite the fact that there are no ligands present in the active site (even 
though the crystallization buffer does contain 50 mM phosphate). Thus, these data 
suggest that the movement of the loop may not be important for substrate binding and 
catalytic activity.  
 
1.9 Unresolved questions and challenges in investigations on Pin1 structure and 
function 
Pin1 is apparently involved in many essential cellular processes and it is indeed 
the only PPIase identified so far that is essential for cell growth. However, it remains 
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to be investigated why the Pin1 gene is essential in some systems but not in others 
(Lu et al., 2002a). Moreover, Pin1 function is very likely depended on the cell type 
and the specific signaling cascades that determine the fate of these cells (Wulf et al., 
2005). Thus, one prominent challenge would be to further define the specificity of 
Pin1 function in different cell types or systems. A number of crystal and NMR 
structures have been solved for human Pin1 as well as for some of its homologues. 
Together with biochemical studies, substantial information on the enzymatic 
specificity and its catalytic mechanism has been gathered. However, there are still a 
lot of uncertainties on Pin1’s mechanism of action and how exactly Pin1 does exert an 
action towards such a broad spectrum of substrates. This uncertainty has been largely 
due to the lack of available structural information on Pin1’s phosphorylated substrates 
(Wulf et al., 2005). Furthermore, it is still also a challenge for researchers to come up 
with a consensus sequence recognized by Pin1. Major challenges in the Pin1 field 
would also include defining the structural and functional differences of the cis and 
trans phosphorylated proteins, and to further develop tools to visualize Pin1-catalyzed 
conformational changes and to study their biological and pathological significance 







CHAPTER 2: OBJECTIVES 
 
 Pin1 is essential in a diverse array of cellular processes for regulating the 
function of a large number of critical proteins through catalysis of 
cis/trans-isomerization of the peptide bond preceding proline, in the sequence of 
pSer/Thr-Pro, thus inducing a conformational change in these substrate proteins.  
Through extensive studies on Pin1, more than 50 biological substrates of Pin1 have 
been identified so far. The first crystal structure of Pin1 has been reported in 1997, 
and this was followed by another crystallographic analysis and several NMR 
structural determinations along with the short peptide substrate complex (2 to 7 
residues). However, much remains to be learned about Pin1’s catalytic mechanism 
and its interaction with biological substrates. In this project, we focused on the 
structural and functional studies on Pin1 mutants in order to better understand Pin1’s 
mechanism of action, and how exactly Pin1 exerts its action to its substrates.  
 
Mutants for this study were selected based on functionally important amino acid 
residues in Pin1 according to the literature. These residues include those that are 
involved in the peptide binding groove in the WW domains: Arg-14, Ser-16, Arg-17, 
Tyr-23, Phe-25, Ser-32, and Trp-34 (Verdecia et al., 2000), and those that are involved 
in substrate specificity and catalytic activity in the PPIase domain: His-59, Lys-63, 
Arg-68, Arg-69, Cys-113, Leu-122, Met-130, Phe-134, Ser-154, and His-157 
(Ranganathan et al., 1997). An alanine screening for these residues was performed by 
first substituting them with alanine. Besides, double mutant R68A/R69A was made 
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because Arg-68 and Arg-69 are twin residues involving in phosphate binding and 
acting as a selectivity filter at the WW domain (Ranganathan et al., 1997). Ser-16 was 
also substituted with Glu which is a negatively charged residue. Substitution of Ser 
with Glu mimics phosphorylation at this side and would provide us structural and 
functional details of how phosphorylation at this side would abolish Pin1’s ability to 
interact with its substrates (as reviewed in section 1.6). These were summarized in 
Table 2-1. 
 
Table 2-1. Functionally important amino acid residues selected for Pin1 mutation studies. 
















Positively charged residues involved in phosphate 
binding 




Together with C113, involved in covalent catalytic 




Proline binding pocket 
 
The techniques involved in this project included the basic molecular cloning, 
site-directed mutagenesis, mammalian cell culture, and protein expression and 
purification. The particular methods in structural biology included circular dichroism 
(CD) and X-ray crystallography. Purified mutant proteins were subjected to 
thermo-stability testing by CD analysis. Pin1 mutant crystals were grown for X-ray 
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crystallographic analyses. We successfully solved seven mutant Pin1 structures: R14A, 
F25A, S32A, W34A, K63A, C113A, and M130A, while crystals for the rest of the 
mutants were failed to be obtained. Mutants’ crystal structures and in vitro peptide 
binding assay combined with functional studies in mammalian cells was planned. 
Together, these studies would provide a deeper understanding of Pin1’s mechanism of 
action and perhaps eventually lead to effective Pin1-based drug design. 
 
 
Figure 2-1: Project work flow chart 
 
1st attempt: Cloning into pET42a+ expression vector – 
protein expressed without any tag 
 2nd attempt: Cloning into pET28b+ expression vector – 
protein expressed with His tag 
 
Molecular cloning of Pin1 / PCR-based site-directed mutagenesis 
•Constructs in pET28b+ vector was used for the project 
 
Large-scale protein expression in E. coli
Protein purification 
1st step: Affinity chromatography (Ni+ beads) 
for His-tag fusion Pin1 protein 
Thrombin digest: cleaving His tag from Pin1 protein
 
2nd step: Gel filtration chromatography 
 
Circular dichroism (CD) analysis X-ray crystallography 
Growing protein crystals by hanging drop method 
 X-ray diffraction 
Pin1 mutant structures solved by molecular replacement analysis 
 
Thermastability testing by 
thermo-denaturation 
Cloning into pEGFP-C1 mammalian 
expression vector – protein expressed to 
be tagged with EGFP at N-terminus 
 
Protein expression in mammalian cells 
Examination of Pin1 mutants’  
cellular localization 
 65
CHAPTER 3: MATERIALS AND METHODS 
 
3.1 Materials 
3.1.1 cDNA constructs, expression vectors and primers 
Pin1 cDNA was reported previously (Gene bank accession number 
NM_006221) and the wild-type, W34A, K63A, S16A, and S16E mutant cDNA 
constructs were kindly provided by Prof. Kun Ping Lu. pET42a+ and pET28b+ 
vectors were purchased from Novagen (Madison, WI) whereas pEGFP-C1 vector was 
from BD Biosciences Clontech (Palo Alto, CA, USA). PCR and sequencing primers 
were purchased from either Sigma-Proligo (Singapore) or 1ST Base Pte Ltd 
(Singapore). 
  
3.1.2 Enzymes and proteases 
Most restriction enzymes were purchased from Promega Corporation 
(Madison, WI) except Dpn I was from New England Biolabs (Beverly, MA, USA). T4 
DNA ligase and Taq DNA polymerase were from Promega Corporation (Madison, 
WI), whereas PfuTurbo® DNA polymerase and thrombin was purchased from 
Stratagene (La Jolla, CA, USA) and Sigma-Aldrich (Singapore), respectively. 
 
3.1.3 Bacterial culture media and other reagents 
Luria Bertani broth (LB) and terrific broth (TB) were purchased from AMRESCO 
(USA) and Amersham Biosciences (Buckinghamshire, UK), respectively. Antibiotics 
kanamycin was from USB Corporation (Cleveland, OH, USA).  
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3.1.4 Mammalian cell lines, cell culture media and other reagents 
 Human cervical cancer cells line HeLa and Chinese hamster ovary (CHO) cells 
were purchased from the American Type Culture Collection (ATCC), (Manassas, VA, 
USA). Dulbeco’s Minimum Eagles Medium (DMEM) and fetal bovine serum (FBS) 
were from Hyclone (Logan, UT). The antibiotics penicillin and streptomycin were 
from Invitrogen Pte. Ltd. Lipofectamine 2000 and Effectene transfection reagents 
were purchased from Invitrogen Pte Ltd (Carlsbad, CA, USA), and Qiagen GmbH, 
(Hilden, Germany), respectively. Tissue culture flasks, culture dish, 12-well plates and 
other disposables were either from Nunc (Roskilde, Denmark) or Falcon (Oxnard, CA, 
USA). Cell cycle drugs nacodazole, hydroxyurea and thymidine were all purchased 
from Sigma-Aldrich (Singapore). 
 
3.1.5 Western blot reagents 
 Pin1 antibody was generated as described previously (Lu et al., 1999). Anti 
His-tag (sc-8036), anti β-tubulin (sc-5274), anti GFP (sc-8334), and goat anti-mouse 
(sc-2005) or anti-rabbit (HRP conjugated) (sc-2004) antibodies were purchased from 
Santa Cruz Biotechnology (CA, USA). Derivatized polyvinylidene difluoride (PVDF) 
membrane was purchased from Amersham Biosciences (Buckinghamshire, UK). 
SuperSignal West Pico Chemiluminescent Substrate was from Pierce Chemical Co. 
(Rockford IL, USA). 
 
3.1.6 DNA cleanup, plasmid DNA preparation, and DNA cycle sequencing kits 
 QIAquick gel extraction kit, QIAquick PCR purification kit, and mini-plasmid 
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preparation kit were all purchased from Qiagen GmbH (Hilden, Germany). The ABI 
PRISM BigDye terminator cycle sequencing ready reaction kit and Hi-Di formamide 
were from Applied Biosystems (Foster City, CA, USA). 
 
3.1.7 Protein purification and crystallization-related materials and reagents 
Ni-NTA agarose was purchase from Qiagen Gmb H (Hilden, Germany). UNO ion 
exchange and Bio-Scale ceramic hydroxyapatite Type I (CHT-I) columns were from 
Bio-Rad (CA, USA) whereas HiPrep 26/60 Sephacryl S-200 High Resolution and 
HiLoad 16/60 Superdex 75 Prep Grade gel filtration columns were from Amersham 
Biosciences (Buckinghamshire, UK). Amicon Ultra-15 and Amicon Ultra-4 
centrifugal filter units were from Millipore (Bedford, MA, USA). Crystallization 
plates (EasyXtal Tool X-seal) were from Qiagen GmbH (Hilden, Germany) whereas 
the other crystallization tools were from Hampton Research (CA, USA).  
 
3.2 Methods 
3.2.1 Molecular cloning 
 In general, DNA fragment (see Figure 3-1) to be cloned into a specific vector was 
amplified by polymerase chain reaction (PCR) in a 50μl reaction mix (3.2 pmol 
forward and reverse primers, 10mM dNTP, and 1 U DNA polymerase) with 35 
thermal cycles (95ºC 1 min, 58ºC 1 min, and 72ºC 1 min; final extension at 72ºC for 
5 min). The sequence of the primers includes the sequence recognized by specific 
restriction enzymes selected for the cloning. To clone Pin1 or mutant cDNAs into 
pET42a+ expression vector at NdeI and Sal I cloning sites, forward and reverse 
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primers were designed as 5’ GTA GTA CAT ATG GCG GAC GAG GAG AAG CTG 
3’ (the NdeI recognition sequence is underlined), and 5’ GTA GTA GTC GAC TCA 
CTC AGT GCG GAG GAT GAT GTG 3’ (the Sal I recognition sequence is 
underlined), respectively (Figure 3-1). The same set of primers were used to clone 
Pin1 or mutants cDNA into pET28b+ expression vector at Nde I and Sal I cloning 
sites so that the Pin1 protein expressed would have a 6X His-tag at its N-terminus 
partitioned by a thrombin cutting site (Figure 3-2). To clone Pin1 or mutant cDNAs 
into pEGFP-C1 mammalian expression vector, Bgl II and Sal I were used as the 
cloning sites with the forward and reverse primers designed as 5’ GTA GTA AGA 
TCT ATG GCG GAC GAG GAG AAG CTG 3’ (underlined is Bgl II recognition 
sequence) and 5’ GTA GTA GTC GAC TCA CTC AGT GCG GAG GAT GAT GTG 
3’ (underlined is Sal I recognition sequence), respectively. Proteins expressed would 
have an enhanced green fluorescent protein (EGFP) fused to its N-terminus (Figure 
3-3). 
 
After DNA amplication by PCR, the PCR product was subjected to agarose gel 
electrophoresis and the amplified DNA fragment was purified by gel extraction kit 
according to the manufacturer’s instruction. In brief, the DNA band was cut out from 
the agarose gel and incubated with gel extraction buffer (100µl per 0.1 gram of 
cut-out gel) at 50 ºC until the gel was dissolved. The dissolved gel solution was then 
applied to a spin column and centrifuged at 13, 000 rpm for 1 min to let the solution 
flowed through the spin column membrane while DNA fragments remained bound to 
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the membrane. To wash the bound DNA, 750 µl of wash solution was added to the 
column and spin column was subjected to centrifugation again. This washing step was 
repeated once, followed by DNA elution with 50 µl of DNase-free water (autoclaved 
distilled water). It was then followed by digestion overnight at 37ºC by appropriate 
restriction enzymes.  
 
After digestion, the insert DNA was purified with PCR extraction kit according to 
the manufacturer’s instruction. Briefly, 3 volumes of Buffer PE was added to the DNA 
digestion mixture followed by applying the mixture into the spin column, and spin 
column was processed as above.  
 
On the other hand, vectors were digested at 37ºC for 4 hr by appropriate 
restriction enzymes and purified by the gel extraction kit as described. Ligation was 
performed by incubating insert DNA fragment and vector with T4 DNA ligase 
overnight at 16ºC. The ligation mixture was then incubated with E. coli BL21 (DE3) 
competent cells for transformation and the recombinant plasmid was verified by 
automated DNA sequencing. 
 
3.2.2 PCR-based site-directed mutagenesis 
Wild type Pin1 recombinant plasmid was used as template for mutagenesis. 
Template-specific mutagenic primers (see Table 3-1) were designed for the 
PCR-based site-directed mutagenesis (with reference to Stratagene’s QuikChange® 
Site-Directed Mutagenesis Kit). Briefly, a 50 μl reaction system containing 5-50ng 
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   B 
    1   ATGGCGGACG AGGAGAAGCT GCCGCCCGGC TGGGAGAAGC GCATGAGCCG CAGCTCAGGC CGAGTGTACT 70 
    71  ACTTCAACCA CATCACTAAC GCCAGCCAGT GGGAGCGGCC CAGCGGCAAC AGCAGCAGTG GTGGCAAAAA 140  
    141 CGGGCAGGGG GAGCCTGCCA GGGTCCGCTG CTCGCACCTG CTGGTGAAGC ACAGCCAGTC ACGGCGGCCC 210  
    211 TCGTCCTGGC GGCAGGAGAA GATCACCCGG ACCAAGGAGG AGGCCCTGGA GCTGATCAAC GGCTACATCC 280  
    281 AGAAGATCAA GTCGGGAGAG GAGGACTTTG AGTCTCTGGC CTCACAGTTC AGCGACTGCA GCTCAGCCAA 350  
    351 GGCCAGGGGA GACCTGGGTG CCTTCAGCAG AGGTCAGATG CAGAAGCCAT TTGAAGACGC CTCGTTTGCG 420 
    421 CTGCGGACGG GGGAGATGAG CGGGCCCGTG TTCACGGATT CCGGCATCCA CATCATCCTC CGCACTGAGT 490 
    491 GA 492 
   C 
 
 
Figure 3-1: Cloning of Pin1-WT and its mutants into pET42b+ vector. (A) Schematic 
diagram of Pin1 protein. (B) Full-length cDNA sequence of hPin1. Nucleotides 1-117 encode 
WW domain (in Italic). Nucleotides 118-132 are linker regions (in bold), whereas the 
nucleotides 133-492 are PPIase domain region. Sequences of WW domain and PPIase 
Underlined are the primers’ positions. (C) Cloning and expression regions of pET42 series 
vector. Cloning sites were boxed in red. 











Figure 3-2: Cloning of Pin1-WT and its mutants into pET28b+ vector. Schematic 
diagram of pET28b+ vector (upper panel) and its multiple cloning site (lower panel). Cloning 








Figure 3-3: Cloning of Pin1-WT and its mutants into pEGFP-C1 vector. Schematic 
diagram of pEGFP-C1 vector (upper panel) and its multiple cloning site (lower panel). 
Cloning sites, which is Bgl II and Sal I, were boxed in red. The protein expressed was EGFP 
tagged fusion protein. 
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Pin1 wild-type plasmid, 0.25 μM of sense and antisense mutagenic primers 
respectively, 0.2 μM dNTPs, and 2.5 U of PfuTurbo® DNA polymerase was subjected 
to 16 thermal cycles (95 °C 1 min, 55 °C 1 min, and 72 °C 6 min; final extension at 
72 °C for 20 min). 15 μl of the PCR products were then treated for 2 hr with 5 U of 
Dpn I at 37 °C for the digestion of the methylated, non-mutated parental DNA 
template. The mixture was then incubated with 100 μl of E. coli BL21 (DE3) 
competent cells for the transformation of the remaining undigested mutated plasmids 
into the bacteria. The mutant sequences were verified by automated DNA sequencing. 
 
   Table 3-1: Mutagenic Primers 
Pin1 mutants Primer Sequence 
S32A 
 
Sense     5’ CCA CAT CAC TAA CGC CGC ACA GTG GGA GCG GCC 3’ 
Antisense  5’ GGC CGC TCC CAC TGT GCG GCG TTA GTG ATG TGG 3’ 
F25A 
 
Sense     5’TCA GGC CGA GTG TAC TAC GCA AAC CAC ATC ACT AAC GCC 3’ 
Antisense  5’ GGC GTT AGT GAT GTG GTT TGC GTA GTA CAC TCG GCC TGA 3’ 
C113A 
 
Sense     5’ CCT CAC AGT TCA GCG ACG CAA GCT CAG CCA AGG CC 3’ 
Antisense  5’ GGC CTT GGC TGA GCT TGC GTC GCT GAA CTG TGA GG 3’ 
H59A 
 
Sense     5’ GGG TCC GCT GCT CGG CAC TGC TGG TGA AGC ACA 3’ 
Antisense  5’ TGT GCT TCA CCA GCA GTG CCG AGC AGC GGA CCC 3’ 
H157A 
 
Sense     5’ CAC GGA TTC CGG CAT CGC AAT CAT CCT CCG CAC TG 3’ 
Antisense  5’ CAG TGC GGA GGA TGA TTG CGA TGC CGG AAT CCG TG 3’ 
S154A  
 
Sense     5’ CCC GTG TTC ACG GAT GCA GGC ATC CAC ATC ATC 3’ 
Antisense  5’ GAT GAT GTG GAT GCC TGC ATC CGT GAA CAC GGG 3’ 
L122A 
 
Sense     5’ AGG CCA GGG GAG ACG CAG GTG CCT TCA GCA GAG 3’ 
Antisense  5’ CTC TGC TGA AGG CAC CTG CGT CTC CCC TGG CCT 3’ 
M130A 
 
Sense     5’ CCT TCA GCA GAG GTC AGG CAC AGA AGC CAT TTG AAG ACG 3’ 
Antisense  5’ CGT CTT CAA ATG GCT TCT GTG CCT GAC CTC TGC TGA AGG 3’ 
R14A 
 
Sense     5’ CCC GGC TGG GAG AAG GCA ATG AGC CGC AGC TCA 3’ 
Antisense  5’ TGA GCT GCG GCT CAT TGC CTT CTC CCA GCC GGG 3’ 
R17A 
 
Sense     5’ GAG AAG CGC ATG AGC GCA AGC TCA GGC CGA GTG 3’ 
Antisense  5’ CAC TCG GCC TGA GCT TGC GCT CAT GCG CTT CTC 3’ 




3.2.3 Preparation of competent cells 
To prepare E. coli BL21 (DE3) competent cells, BL21 (DE3) bacteria strain was 
inoculated in 50 ml LB broth at 37 °C until cell density reached an optical density at 
600 nm (OD600) of 0.6. The cells were then chilled on ice for 10 min followed by 
centrifugation at 2,500 rpm at 4 °C for 10 min. The bacterial pellet was resuspended 
gently in 17 ml CCMB buffer (80 mM CaCl2, 20 mM MnCl2, 10 mM MgCl2, 10 mM 
KOAc, 10 % (v/v) glycerol, and adjusted with HCl to pH 6.4) and incubated on ice 
for 20 min. After centrifugation at 3,000 rpm at 4 °C for 10 min, the cell pellet was 
resuspended again in 4 ml CCMB buffer and stored at -80 °C in small aliquots. 
 
3.2.4 Transformation  
 Transformation was performed using the conventional heat-shock method 
(Seidman et al., 1997). In brief, ligation mixture or recombinant plasmids were gently 
mixed with 100 μl of E.coli BL21 (DE3) competent cells and the mixtures were 
placed on ice for 30 min prior to heat-shock. The mixtures were then subjected to 42 
ºC for 90 s for heat-shock and quickly placed on ice for 5 min. The mixtures were 
then incubated for 1 hr with LB for recovery and subsequently plated onto agar plates 
supplemented with 50 µg/ml antibiotic kanamycin. Plates were incubated overnight at 
37 ºC. Transformant colonies were obtained the next day and the presence of inserts 
was verified by PCR and restriction digestion. Colonies were picked and allowed to 
grow overnight into liquid culture followed by plasmid extraction and purification 
using Miniprep DNA purification kit. The plasmid sequences were then verified by 
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automated DNA sequencing. 
 
3.2.5 Mini-plasmid preparation 
 Recombinant plasmid DNA was extracted from liquid bacterial culture at room 
temperature using Mini-plasmid preparation kit according to the manufacturer’s 
instruction (Qiagen GmbH (Hilden, Germany). In brief, 1-5 ml of bacteria liquid 
culture was harvested by centrifuging at 13, 000 rpm for 1 min. The bacteria pellet 
was resuspended in 250 μl of resuspension buffer (50 mM Tris-HCl (pH 8.0), 10 mM 
EDTA, 100 μg/ml RNase A) followed by adding of 250 μl of lysis buffer (200 mM 
NaOH, 1 % SDS (w/v)). After gentle and thorough mixing for 5 min, 350 μl of 
neutralization buffer was added, followed by centrifuging at 13, 000 rpm for 15 min. 
The supernatant, which contained the plasmid DNA, was then applied to a spin 
column and centrifuged at 13, 000 rpm for 1 min to let the solution flowed through 
the spin column membrane while the plasmid DNA remained adsorbed to the 
membrane. To wash the bound plasmid, 750 μl of wash solution was added to the 
column and spin column was subjected to centrifugation again. This washing step was 
repeated once, followed by plasmid elution with 50 μl of DNase-free water 
(autoclaved distilled water). 
 
3.2.6 Automated DNA sequencing 
 The ABI PRISM® BigDye terminator cycle sequencing ready reaction kit 
(Applied Biosystems) was used for automated cycle sequencing. Recombinant 
plasmid DNA was first extracted from liquid bacterial culture using Miniprep DNA 
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purification kit as described earlier. Subsequently, a reaction system of 20 μl 
consisting of 2 μl BigDye terminators, 3.2 pmol of either forward or reverse 
sequencing primer, 2 μl of purified plasmid DNA template, and 3 μl of 5X reaction 
buffer (400 mM Tris-HCl (pH 9.0), 10 mM MgCl2) was subjected to 35 thermal 
cycles (95 °C 1 min, 58 °C 1 min, and 72 °C 1 min; final extension at 72 °C for 5 
min). The extension products were then precipitated with 80 μl of ethanol-sodium 
acetate solution (consisting of 3 μl of 3 M sodium acetate, pH 4.6, 62.5 μl of 
non-denatured 95 % (v/v) ethanol, and 14.5 μl of deionized water) for 15 min at room 
temperature. After centrifugation at 13,000 rpm for 20 min, the DNA pellet was wash 
twice with 70 % (v/v) ethanol, with an incubation time of 5-15 min each time, 
followed by centrifugation at 13,000 rpm for 10 min. The DNA pellet was allowed to 
dry and was resuspended in 170 μl of Hi-Di Formamide. The resuspended DNA was 
heated at 95 ºC for 2 min to denature the DNA strands and was then immediately 
placed on ice. 10 μl of the DNA was dispensed into a 96-well microtiter place and 
sent to ABI PRISM® 3100 DNA Sequencer for automated DNA sequencing. The 
sequencing results were viewed and analyzed by the software Vector NTI (Invitrogen, 
CA, USA).  
 
3.2.7 Small-scale protein expression 
 1.5 ml overnight inoculated E. coli BL21 (DE3) containing Pin1 plasmid (or 
mutants) was added to 8.5 ml fresh LB supplemented with 50 μg/ml kanamycin and 
was grown at 37 °C with shaking at 250 rpm until the optical density at 600nm 
reached 1.0. The recombinant Pin1 proteins were then induced with 0.8 mM isopropyl 
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β-D-1-thiogalactopyranoside (IPTG) for 4 hr. 1 ml of E. coli culture was sampled for 
harvest by centrifugation at 13,000 rpm for 1 min and the cells were resuspended in 
50 μl E.coli lysis buffer (1 % glycerol, 50 mM Tris-HCl (pH8.0), 0.15 M NaCl, 1 % 
Triton-X100, 1 mM DTT, and 2 mM EDTA) followed by 3 freeze-thaw cycles using 
liquid nitrogen to ensure complete lysis. After centrifugation at 13,000 rpm for 20 min 
at 4 ºC, the supernatant and pellet were separated and the protein expression was 
examined by SDS-PAGE.  
 
3.2.8 Large-scale protein expression 
E. coli cells were grown in 2 L terrific broth supplemented with 50 μg/ml 
kanamycin at 37 °C with shaking at 250 rpm until the optical density at 600nm 
reached 1.0. The recombinant Pin1 proteins were then induced with 0.4 mM IPTG for 
4 hr. E. coli were harvested by centrifugation at 4600×g for 30 min and resuspended 
in 30 ml cold sonication buffer (25 mM Tris-HCl (pH8.0), 0.5 M NaCl, 10mM 
β-mercaptoethanol, and 1% (v/v) Tween-20). The cells were sonicated on ice for 10 
min at 30 s burst cycles at 300 W with a 30 s cooling period between each burst. The 
cleared lysate were obtained by ultra-centrifugation at 18,000×g for 30 min followed 
by an additional step of filtering through 0.45 μm syringe filters. The cleared lysate 
was then ready for protein purification. 
 
3.2.9 Protein purification 
3.2.9.1 Gel filtration (HiPrep 26/60 Sephacryl S-200 High Resolution) 
 Bacterial crude lysate was loaded onto a HiPrep 26/60 Sephacryl S-200 High 
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Resolution column equilibrated in an elution buffer containing10 mM HEPES-Na+ 
(pH 7.5), 100 mM NaCl, and 1 mM DTT, with a flow rate of 1.3 ml/min controlled by 
a peristaltic pump. Fractions of 6 ml were collected and the protein content was 
monitored by a spectrophotometer at 280 nm. Pin1-containing fractions were 
identified by SDS-PAGE and Western blot. The positive fractions were pooled 
together for the second step of purification. 
 
3.2.9.2 Ion-exchange chromatography 
 Pin1-containing fractions from gel filtration described above were subjected to 
UNO ion exchange S-6 column (column volume = 6 mL) equilibrated in Buffer A (10 
mM HEPES-Na+ (pH 7.5), 100 mM NaCl) with a flow rate of 1 ml/min in a fast 
performance liquid chromatography (FPLC) system (Biologic DuoFlow™ 40 System, 
Bio-Rad, CA, USA). After injection of sample, 4 column volume of 24 mL of Buffer 
A was allowed to flow isocratically for the binding of proteins unto the cation 
ion-exchanger. Salt gradient from 0 % to 100 % Buffer B (10 mM HEPES-Na+ (pH 
7.5), 1 M NaCl) in 60 ml was performed for protein elution and fractions of 2 ml were 
collected. The fractions were analyzed for Pin1 by SDS-PAGE and Western blot. To 
optimize the protein purification, pH or ionic strength of Buffer A and B were varied. 
 
To complement the ion-exchange chromatography, CHT-I column was employed. 
Protein sample after gel filtration was loaded onto the column equilibrated with 
Buffer C (10 mM sodium phosphate (pH 6.8)) with a flow rate of 1 ml/min. After 
injection of sample, 3 column volume of Buffer C was allowed to flow isocratically 
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for the binding of proteins onto the column matrix. Salt gradient from 0 % to 100 % 
Buffer D (500 mM sodium phosphate (pH 6.8) in 60 ml was performed for protein 
elution and 2 ml fractions were collected. The fractions were analyzed for Pin1 by 
SDS-PAGE and Western Blot. 
 
3.2.9.3 His-tag fusion protein purification and gel filtration (HiLoad 16/60 
Superdex 75 Prep Grade column) 
Bacterial crude lysate was incubated with 2.5 ml Ni-NTA agarose bead slurry 
(Qiagen, Hilden, Germany) with gentle shaking at 4 °C for 3 hr and loaded into an 
empty glass Econo-Column column (2.5 cm × 10 cm, Bio-Rad, CA, USA). The 
recombinant proteins were eluted with 10 ml elution buffer (sonication buffer minus 
Tween-20 and supplemented with 250 mM imidazole) after washing with 20 ml wash 
buffer (sonication buffer minus Tween-20 and supplemented with 5 mM imidazole). 
To cleave 6X His-tag from the fusion protein, the eluted protein was incubated with 
thrombin (5U per mg protein) (Sigma, St. Louis, MO, USA) at 4 °C for 18 hr. To 
further purify, the cleaved fraction was fractionated by a HiLoad 16/60 Superdex 75 
Prep Grade gel filtration column (Pharmacia, New Jersey, USA) equilibrated in 
elution buffer containing 5mM HEPES-Na+ (pH 7.5), 100 mM NaCl, and 1 mM DTT 
with a flow rate of 1 ml/min. Fractions of 1 ml were collected. Pin1-containing 
fractions were pooled and concentrated to at least 100 mg/ml with an Amicon 
Ultra-15 centrifugal unit (Millipore, Bedford, MA) with a molecular mass cutoff at 5 
kDa. The purified Pin1 protein was stored at -80 °C for further application.  
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3.2.10 Protein concentration assay 
Pin1 protein concentrations were quantified using the Bradford method (Bradford, 
1976). Bovine serum albumin (BSA) was used as the protein standard, ranging from 
0-10 μg/ml. 800 μl of the protein standards or protein samples was mixed with 200 μl 
of the Bradford protein assay reagent from Bio-Rad (CA,USA), and incubated at 
room temperature for 10 min. The absorbance was then read at wavelength of 595 nm 
and the protein concentration in the samples was determined by comparing to the 
BSA standard curve. 
 
3.2.11 Agarose gel electrophoresis 
 Agarose gels were cast with the Bio-Rad gel casting system. Typically, for most 
Pin1 clones, the gels contain 1 % (w/v) agarose in TAE buffer (40 mM Tris base, 20 
mM acetic acid, 1mM EDTA pH 8.0) supplemented with 0.5 μg/ml ethidium bromide. 
DNA samples were mixed with 6X sample buffer (10 mM Tris-HCl (pH 7.6), 0.03 % 
(w/v) bromophenol blue, 0.03 % (w/v) xylene cyanol, 60 % (v/v) glycerol, and 60 
mM EDTA) and loaded onto the gels. Gel electrophoresis was typically carried out in 
TAE buffer at a constant voltage of 100 V for 40 min. 
 
3.2.12 Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) 
 SDS-PAGE gels were cast with the Bio-Rad miniprotein III gel casting system. 
The resolving gel contains 10 % of acrylamide/bisacrylamide mixture (30% with a 
ratio of 29:1) in 0.375 M Tris-HCl (pH 8.8) and 0.1 % SDS. The stacking gel contains 
4 % acrylamide/bisacrylamide in 0.125 M Tris-HCl (pH 6.8) and 0.1 % SDS. 
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Polymerization was induced by the addition of 1 % ammonium persulphate (APS) and 
N,N,N,N,-Tetramethyl-Ethylenediamine (TEMED). Protein samples were mixed with 
2X SDS sample buffer (100 mM Tris-HCl (pH 6.8), 4 % (w/v) SDS, 200mM 
dithiothreitol (DTT), 20 % (v/v) glycerol and 0.2 % (w/v) bromophenol blue) and 
heated at 95 ºC for 5 min before loading onto the gel. Gel electrophoresis was 
typically carried out in Tris-Glycine buffer (25 mM Tris-base, 192 mM Glycine and 
0.1 % (w/v) SDS) at a constant voltage of 120 V for 2 h. 
 
3.2.13 Coomassie blue staining and destaining of SDS-PAGE gel 
 The SDS-PAGE gel is stained in Coomassie Brilliant Blue staining solution (0.25 
% (w/v) Coomassie Blue R-250 in 50 % methanol and 10 % acetic acid) at room 
temperature with shaking for 30 min. The gel is then destained with destaining buffer 
(30 % methanol and 10 % acetic acid) until the background staining was cleared. 
 
3.2.14 Western blot analysis 
 After SDS-PAGE, the separated proteins were transferred onto a PVDF 
membrane. The transfer was carried out in transfer buffer (0.3 % (w/v) Tris-base, 1.4 
% (w/v) glycine and 20% (v/v) methanol) with a Bio-Rad semi-dry transfer apparatus 
at constant current of 180 mA for 45 min (typically for Pin1 protein). The membrane 
was then blocked overnight with 5 % skim milk plus 1 % BSA in TBST (25mM 
Tris-base (pH 7.4), 137 mM NaCl, 0.05 % (v/v) Tween-20) at 4ºC followed by 
incubations with specific primary antibodies for 1 hr and appropriate secondary 
antibodies conjugated with horse radish peroxidase (HRP) for 1 hr. All the antibodies 
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were diluted in TBST. Membranes were washed three times with TBST after each 
antibody incubation step. Immunoreactive signals were visualized using a 
chemiluminescent substrate (Supersignal West Pico Chemiluminescence Substrate, 
Pierce) and X-ray films (Fuji SuperRX Film, Fuji, Japan), which were developed 
using a Kodak X-ray film processor. 
 
3.2.15 Mass spectrometry (MS) 
 Protein bands were excised from Coomassie Blue-stained SDS-PAGE gel and 
sent to Protein and Proteomic Center (PPC) (Department of Biological Sciences, 
National University of Singapore) for mass spectrometry analysis. 
 
3.2.16 Circular dichroism (CD) 
CD measurements were conducted using a Jasco J-810 spectropolarimeter (Tokyo, 
Japan) equipped with a Neslab RIE-111 water-circulated thermal controller using 1 
mm path-length cuvettes with a 0.1 nm spectral resolution. The samples with a protein 
concentration of 0.5 mg/ml were prepared in 5mM HEPES-Na+ (pH7.5) with or 
without supplementing 10mM phosphate. For wavelength scans in the far UV regions 
(260-190 nm), each spectrum was obtained at 20 °C by averaging three successive 
accumulations with a wavelength step of 0.2 nm at a rate of 20 nm/min, response time 
1 s, and band width 1 nm. All spectra were corrected for buffer contributions and 
converted to mean residue ellipticity ([Θ]) using the following equation: 
 
[Θ] = (MRW.θλ)/10.l.c 
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where MRW is the mean residue weight (a value of 111.3 was used for the WT), θλ is 
the measured ellipticity in degree at wavelength λ, l is the cuvette path length (0.1 cm), 
and c is the protein concentration in mg/ml. The secondary structure analysis was 
performed using the K2d programme, which provides an interactive web site server 
allowing the deconvolution of data from CD spectroscopy experiments 
(www.embl-heidelberg.de/~andrade/k2d/).  
 
Thermal stability of proteins were analyzed by monitoring the changes in 
ellipticity at 202 nm continuously at the temperature range between 20 °C and 90 °C, 
with heating rates of 1.5 K/min. The temperature at which half of the protein 
molecules were unfolded was recorded as the melting temperature (Tm). 
 
3.2.17 Protein crystallization and data collection 
Protein crystals were obtained by hanging drop vapor diffusion method 
(McPerson, 1982) at either room temperature or 4 °C by mixing 1μl of concentrated 
Pin1 mutant with 1 μl of a reservoir solution. A series of conditions were screened by 
varying protein concentration (ranging from 20 to 200 mg/ml), temperature (room 
temperature or 4°C) and the reservoir solution. Conditions of the reservoir solutions 
are summarized in Table 3-2. These conditions were modified from crystallization 
conditions of wild type Pin1 or Pin1 homologue published by Ranganathan et al., 




Table 3-2: Conditions of the crystallization reservoir solutions. 
100 mM HEPES-Na+ (pH7.5) 
2.0 M (NH4)2SO4 
1% PEG400 
1 mM DTT 
100 mM MOPS-Na+ (pH7.0) 
28% PEG8000 
2 mM DTT 
100 mM HEPES-Na+ (pH7.5) 
20% PEG8000 
2 mM DTT 
100 mM HEPES-Na+ (pH7.5) 
2.2 M (NH4)2SO4 
1% PEG400 
1 mM DTT 
100 mM MOPS-Na+ (pH7.0) 
30% PEG8000 
2 mM DTT 
100 mM HEPES-Na+ (pH7.5) 
22% PEG8000 
2 mM DTT 
100 mM HEPES-Na+ (pH7.5) 
2.5 M (NH4)2SO4 
1% PEG400 
1 mM DTT 
50 mM KH2PO4 (pH7.5) 
10% PEG8000 
0.2 M Ammonium acetate 
 
100 mM HEPES-Na+ (pH7.5) 
24% PEG8000 
2 mM DTT 
100 mM HEPES-Na+ (pH7.5) 
2.0 M (NH4)2SO4 
1% PEG400 
1 mM DTT 
50 mM KH2PO4 (pH7.5) 
12% PEG8000 
0.2 M Ammonium acetate 
 
100 mM HEPES-Na+ (pH7.5) 
26% PEG8000 
2 mM DTT 
100 mM MOPSO-Na+ (pH7.0) 
20% PEG8000 
2 mM DTT 
50 mM KH2PO4 (pH7.5) 
14% PEG8000 
0.2 M Ammonium acetate 
 
100 mM HEPES-Na+ (pH7.5) 
28% PEG8000 
2 mM DTT 
100 mM MOPSO-Na+ (pH7.0) 
22% PEG8000 
2 mM DTT 
50 mM KH2PO4 (pH7.5) 
16% PEG8000 
0.2 M Ammonium acetate 
 
100 mM HEPES-Na+ (pH7.5) 
30% PEG8000 
2 mM DTT 
100 mM MOPSO-Na+ (pH7.0) 
24% PEG8000 
2 mM DTT 
50 mM KH2PO4 (pH7.5) 
18% PEG8000 
0.2 M Ammonium acetate 
 
100 mM MOPS-Na+ (pH7.0) 
2.0 M (NH4)2SO4 
1% PEG400 
1 mM DTT 
100 mM MOPSO-Na+ (pH7.0) 
26% PEG8000 
2 mM DTT 
50 mM KH2PO4 (pH7.5) 
20% PEG8000 
0.2 M Ammonium acetate 
 
100 mM MOPS-Na+ (pH7.0) 
2.2 M (NH4)2SO4 
1% PEG400 
1 mM DTT 
100 mM MOPSO-Na+ (pH7.0) 
28% PEG8000 
2 mM DTT 
100 mM HEPES-Na+ (pH7.5) 
2.0 M (NH4)2SO4 
1% PEG400 
2 mM DTT 
100 mM MOPS-Na+ (pH7.0) 
2.5 M (NH4)2SO4 
1% PEG400 
1 mM DTT 
100 mM MOPSO-Na+ (pH7.0) 
30% PEG8000 
2 mM DTT 
100 mM HEPES-Na+ (pH7.5) 
2.5 M (NH4)2SO4 
1% PEG400 
2 mM DTT 
100 mM MOPSO-Na+ (pH7.0) 
2.0 M (NH4)2SO4 
1% PEG400 
1 mM DTT 
100 mM MOPS-Na+ (pH7.0) 
20% PEG8000 
100 mM HEPES-Na+ (pH7.5) 
2.0 M (NH4)2SO4 
100 mM MOPSO-Na+ (pH7.0) 
2.2 M (NH4)2SO4 
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2 mM DTT 2% PEG400 
1 mM DTT 
1% PEG400 
1 mM DTT 
100 mM MOPS-Na+ (pH7.0) 
22% PEG8000 
2 mM DTT 
100 mM HEPES-Na+ (pH7.5) 
2.5 M (NH4)2SO4 
2% PEG400 
1 mM DTT 
100 mM MOPSO-Na+ (pH7.0) 
2.5 M (NH4)2SO4 
1% PEG400 
1 mM DTT 
100 mM MOPS-Na+ (pH7.0) 
24% PEG8000 
2 mM DTT 
100 mM HEPES-Na+ (pH7.5) 
2.0 M (NH4)2SO4 
2% PEG400 
2 mM DTT 
 
100 mM MOPS-Na+ (pH7.0) 
26% PEG8000 
2 mM DTT 
100 mM HEPES-Na+ (pH7.5) 
2.5 M (NH4)2SO4 
2% PEG400 
2 mM DTT 
 
 
The optimal crystallization condition for wild-type Pin1 and its mutants (R14A, 
S16E, F25A, S32A, W34A, K63A, C113A, M130A) was at 4 °C by mixing 1μl of 
100-200 mg/ml concentrated protein with 1 μl of a reservoir solution consisting of 2.5 
M ammonium sulfate, 100 mM HEPES-Na+ (pH 7.5), 2 % PEG400 (Sigma), and 2 
mM DTT. Protein crystals appeared within 1 week and further grew into appropriate 
sizes of ~0.1 mm within 3 weeks. Crystals were cryoprotected in 40 % (v/v) PEG400, 
50mM HEPES-Na+ (pH 7.5), and 1mM DTT and frozen in a stream of 100K nitrogen 
gas (Oxford Cryosystems, Oxford, UK). X-ray diffraction data were collected using 
an R-axis IV++ image plate detector mounted on a RU-H3RHB rotating anode 
generator (Rigaku Corp., Tokyo, Japan). Synchrotron data was collected at beamline 
X25, National Synchrotron Light Source, Brookhaven National Laboratory using a 
Q315 CCD detector (Area Detector Systems Corp., Poway, CA, USA). All diffraction 
images were integrated and scaled by using the program HKL2000 (Otwinowski and 
Minor, 1997). The Pin1 mutant structures were solved by the molecular replacement 
analysis, using the program MOLREP (Vagin and Teplyakov, 1997) from the CCP4 
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program package (Collaborative Computational Project Number 4, 1994), with the 
structure of Pin1 WT as the search model [PDB code: 1PIN]. All stages of 
crystallographic refinement were carried out with the program CNS (Brunger et al., 
1998) and model building was performed with the program O (Jones et al., 1991). 
Molecular figures were generated in PyMOL (DeLano, 2002) or MOLMOL (Koradi 
et al., 1996).  
 
3.2.16 Cell Culture 
HeLa and CHO mammalian cell lines were maintained in Dulbeco’s Minimum 
Eagles Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and 1% 
antibiotics penicillin and streptomycin at 37 ºC under 5% CO2 and saturated moisture. 
 
3.2.17 Transient transfection and cell cycle synchronization 
The EGFP-Pin1 constructs (in mammalian expression vector pEGFP-C1) were 
transfected into HeLa and CHO cells. Cells were plated onto cover slips in 12-well 
plates and grown for 24 hr to a confluency of 50-60%. Lipofectamine 2000 
(Invitrogen Pte Ltd, Carlsbad, CA, USA) and Effectene Invitrogen Pte Ltd, Carlsbad, 
CA, USA) were used as transfection reagents for HeLa cells and CHO cells, 
respectively, according to the manufacturers’ instructions. Cells were harvested for 
microscopic examination 20 hr after transfection or were treated with drugs 12 hr 
after transfection. To arrest cells at G0 phase, cells were starved in serum-free DMEM 
for 40 hr. To arrest cells at early S phase, cells were treated with 2mM thymidine for 
16 hr. Cells were then released to grow for 9 hr followed by 2mM thymidine 
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treatment for another 15 hr. To arrest cells at S phase, cells were treated with 4mM 
hydroxyurea for 40 hr. To arrest cells at G2/M phase, cells were treated with 2mM 
thymidine for 24 hr and released to grow for 3 hr followed by treatment with 
100ng/ml nocodazole for 12 hr. 
 
3.2.18 Immunofluorescence staining and fluorescence microscopy 
Cells grown on cover slips were fixed in 4% paraformaldehyde for 20 min at 
room temperature. Cells were then rinsed three times with PBS and stained with 
DAPI for 20 min followed by washing with PBS for three times. The cells were then 
analyzed by fluorescent microscopy for EGFP-Pin1 cellular localization. For 
colocalization of EGFP-Pin1 with centrosome, cells were fixed with 4% 
paraformaldehyde for 15 min at room temperature and then with cold pure methanol 
for 10 min. After washing with three times PBS, cells were then stained for 
centrosomes with anti γ-tubulin antibodies (dilution 1:200) (Sigma) and were stained 
for nucleus with DAPI followed by imaging under a fluorescent microscope (Zeiss 








CHAPTER 4: RESULTS AND DISCUSSION 
 
4.1 Molecular cloning and protein expression/purification using the pET42a+ 
expression vector system  
4.1.1 Protein purification strategy I 
 Pin1 protein was generally expressed as His-tagged fusion protein in large-scale 
protein preparation system for structural studies purposes (Bayer et al., 2003; 
Ranganathan et al., 1997; Verdecia et al., 2000). We first attempted to express Pin1 
without any tag, with the following reasonings. First, Pin1 is a relatively small 
molecule with a molecular weight of 18,000 Dalton and it is highly soluble. In past 
experience, Pin1 protein was easily expressed in E. coli. Second, it would be 
preferable to use the native protein without any additional sequences to ensure that the 
protein structure is not locally or globally affected. Thus, the first purification strategy 
was to express the proteins in E. coli BL21 (DE3) strain, followed by purification 
using gel filtration and ion-exchange chromatography (Figure 4-1). 
 
 
Figure 4-1: Protein purification strategy I. 
4.1.2 Molecular cloning of Pin1 
Pin1 cDNA was cloned into the pET42a+ expression vector at the cloning sites, 
Nde I and Sal I, as described in the “Materials and methods” session. First, Pin1 wild 
type and various mutant cDNAs S16A, S16E, W34A, K63A, as well as the the double 
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mutant R68A/R69A (generous gifts from Prof. Lu Kun Ping’s lab) were used as 
templates for PCR to generate various inserts flanked with Nde I and Sal I linkers. 
Various specific bands of approximately 500 bp were obtained (Figure 4-2 A). These 
were excised from agarose gels, followed by DNA fragment purification and 
restriction enzyme digestions with Nde I and Sal I. The DNA fragments were then 
ligated with Nde I- and Sal I-digested pET42a+ vector, followed by transformation 
into E. coli BL21 strain. Most of the transformant colonies selected showed specific 
bands of approximately 500 bp when analyzed by PCR (Figure 4-2 B&C). 
Furthermore, restriction digests also retrieved DNA inserts of approximately 500 bp 
(Figure 4-2 B&C). Thus, these colonies bore the recombinant plasmids. Sequences of 
these inserts were further confirmed by DNA sequencing and the mutated residues for 
W34A, K63A, S16A, S16E, and R68A/R69A were thus verified (data not shown).  
 
 
Figure 4-2: Molecular cloning of Pin1-WT and mutants. (A) Pin1-WT and mutants 
flanked with Nde I and Sal I linkers were obtained via PCR, with an expected size of 513 bp. 
2A denotes the double mutant, R68A/R69A. (B) PCR and restriction digest analysis of BL21 
colonies transformed with recombinant Pin1 wild-type or S16E constructs. (C) PCR analysis 
of Pin1 mutants S16A, W34A, K63A, and R68A/R69A. 
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4.1.3 Site-directed mutagenesis 
 Other Pin1 mutants besides were generated by site-directed mutagenesis as 
described in the “materials and methods” session. Figure 4-3 shows representatively 
the PCR and restriction digestion analysis of the selected transformants. Most of the 
transformants selected contain Pin1 recombinant plasmid. Mutant constructs of R14A, 
R17A, S32A, F25A, C113A, H59A, H157A, S154A, L122A, and M130A were all 
successfully obtained.  




Figure 4-3: Site-directed mutagenesis. (A) PCR analysis of BL21 colonies transformed with 
Pin1 mutant constructs, R17A and R14A, in site-directed mutagenesis. (B) Restriction digest 
analysis for R17A. Numbers (1-4) on the top of the lanes denoted different colonies selected for 
analysis. 
 
4.1.4 Pin1 protein expression 
 Wild type Pin1 and mutant recombinant proteins were expressed in a small scale 
(10 ml) as described in the “materials and methods” session. As representatively 
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shown in Figure 4-4, all the proteins were highly expressed after IPTG induction. 
Moreover, all the proteins were highly soluble and were found in the lysate 
supernatant.  
 
Figure 4-4: Pin1 protein expression. E.coli BL21 (DE3) was induced with 0.8 mM IPTG. E. 
coli were then lysed and separated as supernatant and pellet, followed by SDS-PAGE analysis. 
Coomassie blue staining showed that Pin1 wild type and mutant proteins were highly soluble. 
T: Total protein; S: Supernatant; P: Pellet. 
   
   
4.1.5 First step of Pin1 and mutant protein purification—gel filtration 
chromatography 
 E. coli lysates prepared in large scales (1 l) were passed through a HiPrep 26/60 
Sephacryl S-200 High Resolution gel filtration column with a flow rate of 1.5 ml/min. 
The elution profile of a typical chromatographic experiment was shown in Figure 4-5. 
As verified by SDS-PAGE with Coomassie blue staining and Western blot, Pin1 
protein was eluted between elution volumes of 180 ml and 210 ml. These fractions 









Figure 4-5: Gel filtration chromatography. (A) Elution profile of gel filtration for Pin1-WT. 
Fractions 90-105 (180-210 ml) contained the Pin1 recombinant protein, as shown by 
coomassie blue staining (B, upper panel) and western blot (B, lower panel). All Pin1 mutants 
showed a similar elution profile (not shown). Column used: HiPrep 26/60 Sephacryl S-200 





















4.1.6 Second step of purification—ion-exchange chromatography 
 Fractions from the previous step of gel filtration were passed through an S-6 
cation-exchange chromatography column. The predicted isoelectric point (pI) of Pin1 
is 8.9. In a buffer condition of pH 7.5, Pin1 should be positively charged and bind to a 
cation-exchanger. However, Pin1 failed to bind to the cation-exchanger at all and was 
found in the void volume, as detected by SDS-PAGE and Western blot (Figure 4-6 A). 
Further attempts were made by increasing the solvent buffering capacity from 10 mM 
to 20 mM HEPES-Na+ (pH 7.5), and by decreasing the flow rate from 1 ml/min to 0.6 
or 0.3 ml/min. In these attempts, a portion of Pin1 bound to cation-exchanger and was 
eluted out at the early part of a salt gradient. However, there were still a considerable 
portion of Pin1 (approximately 30%) that had remained unbound in the void volume, 
as gauge by Western blot (Figure 4-6 B). Further increasing of buffering capacity to 
50 mM HEPES-Na+ slightly improved Pin1 binding to the cation exchanger (data not 
shown). Attempts were made to further optimize the cation binding efficiency at pH 
6.8. With both 10 mM and 50 mM HEPES-Na+. However, we observed that a 
considerable portion of Pin1 (approximately 30%) still could not bind to the cation 
exchanger and was eluted out in the void volume (Figure 4-6 C). Further decreasing 
the pH to pH 5.5 totally abolished Pin1 binding to the cation exchanger (data not 
shown).  
 
 Interestingly, when the protein eluted in void volume was loaded onto the 
cation-exchange column again, 60-70% of Pin1 would then bind to the 
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cation-exchanger (data not shown). When Pin1 was loaded unto a quarternary 
ammonium Q column, which is an anion-exchange column, a portion of Pin1 also 
remained unbound in the void volume (data not shown). Nevertheless, the two 
populations of Pin1 (Pin1 in void volume and Pin1 eluted at the early salt gradient 
respectively) were both verified as Pin1 protein by mass spectrometry (MS) (data not 
shown). Furthermore, MS sequencing results showed oxidation of the Pin1 proteins at 
considerable number of methionine residues. Oxidation of methionine residues could 
therefore have altered the net charge, thus the pI, of the protein. To attempt to remedy 
this, E. coli cells were lysed with a buffer containing a reducing agent (1mM DTT) to 
prevent protein oxidation. The lysate was loaded onto the gel filtration column with a 
mobile phase of 10 mM HEPES-Na+, pH 7.5, supplemented with 1mM DTT. 
However, a subpopulation of Pin1 protein still did not bind to the cation-exchange 
column (data not shown). Thus, oxidation of the protein could not fully explain the 
poor binding and the existence of the subpopulations of Pin1. Pin1 protein appears 
therefore to exist in equilibrium between the two populations, which exhibit different 
surface charges.  
 
 The nature of the two populations of Pin1 was not clear and taking either 
population while ignoring the other would not be desirable. Thus, a ceramide 
hydroxyapatite (CHT) column was used in place of the ion-exchange column. Pin1 
fractions from a HiPrep 26/60 Sephacryl S-200 High Resolution gel filtration column 
were loaded onto the CHT column as described in the “Materials and methods” 
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session. As seen in Figure 4-6 D, Pin1 bound tightly to the column and no Pin1 was 
detected in the void volume (as verified by Western blot). Pin1 was eluted out at the 
early part of a salt gradient, in fractions 17 to 23. However, in these fractions, three 
close peaks were observed. In view of the uncertainties observed, we shifted to 







Figure 4-6: Ion exchange chromatography elution profiles and fraction analysis. (A) S-6 
column; buffer system: 10 mM Hepes-Na+ pH 7.5; flow rate: 1 ml/min. (B) S-6 column; 
buffer system: 20 mM Hepes-Na+ pH 7.5; flow rate: 0.6 ml/min. (C) S-6 column; buffer 
system: 10 mM Hepes-Na+ pH 6.8; flow rate: 0.6 ml/min. (D) CHT column; buffer system: 
10 mM sodium phosphate pH 6.8; flow rate: 1 ml/min. Blue lines, red lines, and black lines 
denote absorbancy at 280 nm, conductivity, and percentage of Buffer B (see “materials and 
methods”), respectively. All Western blots were blotted with anti-Pin1 antibody. Samples 
loaded were either of wild type Pin1 or S16E mutant protein. 
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4.2 Molecular cloning and protein expression/purification using the pET28b+ 
expression vector system  
4.2.1 Protein purification strategy II 
 In this alternative purification strategy, Pin1 protein was expressed as 
hexahistidine (His) -tag fusion protein and purified with Ni-NTA affinity 
chromatography specific for the His-tag. The His-tag was then thrombin-cleaved. The 
full-length Pin1 protein was further purified by the second step of gel filtration 
chromatography (Figure 4-7).  
 
 
Figure 4-7: Protein purification strategy II. 
 
 
4.2.2 Molecular cloning of His-Pin1 and protein expression 
Pin1 wild type and mutant cDNAs were subcloned from the constructs in 
pET42a+ vector (from protein purification strategy I) into pET28b+ expression vector 
at cloning sites Nde I and Sal I, such that proteins expressed from the new constructs 
would be His-tagged at the N-terminus, partitioned by a thrombin cleavage site, as 
described in the “Materials and methods” session (cloning data not shown). Wild-type  
Pin1 as well as all the mutant recombinant proteins were highly expressed when 
induced with IPTG, as detected by SDS-PAGE and Western blot with specific 
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anti-Pin1 and anti-His antibodies where the wild type Pin1 recombinant prtein is 
shown as a representative (Figure 4-8). Moreover, the proteins were soluble and were 




Figure 4-8: Expression of His-Pin1 fusion protein. Wild type Pin1 is shown as a 
representative. (A) Coomassie blue staining of SDS-PAGE gel. Pin1 protein was found in the 
supernatant. (B) Western blot analysis. Antibodies used were specific against His-tag (upper 
panel) or Pin1 (lower panel). T: Total protein; S: Supernatant; P: Pellet. 
 
4.2.3 Protein purification—His-tag affinity chromatography and gel filtration 
 After induction with IPTG, cleared E. coli lysate was incubated with Ni-NTA 
agarose beads for 4 hours to allow His-tag fusion protein binding to the beads. The 
bound His-tag fusion protein was eluted with 250 mM imidazole after washing with 
10 mM imidazole, as shown in Figure 4-9 A. The His-tag was then cleaved from the 
fusion protein by incubating with 5 U of thrombin per mg of protein at 4 ºC. Near 
complete cleavage was achieved after 18 h, as monitored by SDS-PAGE and 





 Thrombin digested Pin1 was then loaded onto a HiLoad Superdex 75 Prep Grade 
gel filtration column as described in the “Materials and methods”. Pin1 was eluted out 
as a peak between 60 to 80 ml of elution volume (Figure 4-10 A&B). The Pin1 
proteins (wild type and all the mutant proteins) were at least 98 % pure as verified by 





Figure 4-9: His-tag affinity chromatography of Pin1 recombinant protein. Wild type Pin1 
is shown as a representative. All Pin1 mutants behave in a similar manner. (A) Elution of 
His-Pin1 from Ni+ beads. Bacterial lysate was incubated with Ni+ beads at 4 °C for 4 hours 
followed by stepwise elution with increasing concentration of imidazole. His-Pin1 started to 
be eluted out at 5 mM imidazole, as monitored by SDS-PAGE and Coomassie blue staining. 
(B) Elution of His-Pin1 from Ni+ beads and subsequent thrombin digestion. After washing 
with 5 mM imidazole, His-Pin1 was eluted with 250 mM imidazole followed by incubation 










Figure 4-10: Protein purification by gel filtration chromatography. (A) A gel filtration 
chromatography elution profile. Protein sample was loaded onto a HiLoad Superdex 75 Prep 
Grade column and fractionated with a flow rate of 1 ml/min. Proteins at various peaks were 
analyzed by SDS-PAGE and Coomassie blue staining (B). (C) Final purity of the Pin1 protein 
verified with Coomassie blue staining.  
 
4.3 Secondary structure elements of Pin1 as analyzed by circular dichroism (CD) 
Pin1 proteins were first subjected to circular dichroism (CD) analysis to 




Pin1 in far-UV range (190-260 nm) exhibited a typical spectrum for a polypeptide 
with a mixture of α-helix and β-sheet (Figure 4-11). Data analysis using the K2d 
programme showed that wild type Pin1 contains 15 % and 35 % in the absence, and 
7% and 42 % in the presence of phosphate, of α-helix and β-sheet, respectively (Table 
4-1). However, both α-helix and β-sheet comprises 22 % respectively in a reported 
Pin1 crystal structure (PDB code: 1PIN). Thus, the CD analysis had underestimated 
α-helices but overestimated β-sheets. Indeed all the algorithms used to analyze CD 
data employ certain reference protein sets to estimate the secondary structure of the 
input protein. Drawbacks for each method exist. Nevertheless, all the mutants (such as 
S16A) analyzed showed similar percentage (ranging from 28.5 to 43.7 %) in the 
β-sheet component, suggesting that these have a similar folded structure with that of 
the wild type protein. Wild type Pin1 structure does not differ in the presence or 
absence of phosphate. However, interestingly, the mutants R17A, R68A/R69A, and 
M130A showed significant change in the percentage of β-sheets when phosphate was 
added. The R17A mutant had a decrease in the percentage of β-sheets by 10 %, 
whereas R68A/R69A and M130A had an increase in the percentage by 30 % and 29 
%, respectively. From previous studies, the three basic residues Arg-17, Arg-68, and 
Arg-69 have been shown to be important for phosphate group binding by Pin1 with 
pSer/Thr-Pro motifs. Residue Arg-17 is involved in the WW domain’s interaction with 
pSer5’ in the CTD phosphopeptide (Verdecia et al., 2000), whereas Arg-68 and 
Arg-69 are residues in the tripartite basic cluster that serve as a selectivity filter for 




















































with the important role of these three basic residues in their interactions with the 
phosphate group in the pSer/Thr-Pro motifs. In addition, the residue Met-130 may 
also play a role in the phosphate binding in spite of residing in the hydrophobic 
pocket where the proline residue of the target motif is sequestered (Ranganathan et al., 
1997). No studies have previously investigated the role of Met-130 in the regulatory 
mechanism of Pin1 in detail. Thus, Met-130 may be a new candidate residue 
































Figure 4-11: CD spectra of Pin1 mutants. Pin1 wild type (A), S16A mutant (B), 
R68A/R69A (C), and M130A (D) were subjected to CD analysis in far-UV range (190-260 
nm) at 20 ºC. R68A/R69A and M130A exhibited a slight shift at the positive peak, implying a 



















































Table 4-1: The percentage (%) of the secondary structure elements in Pin1 as analyzed by circular dichroism (CD). Data shown is the average and 
standard deviation from three independent experiments. Data highlighted in bold represent those with significant change between the absence and 
presence of phosphate.  
 
IN THE ABSENCE OF Pi IN THE PRESENCE OF Pi 
  Helix Strand Turns Unordered  Helix Strand Turns Unordered 
WT 15.0 ± 1.4 35.5 ± 0.7 21.0 ± 0.0 28.0 ± 1.4 WT 7.0 ± 1.0 42.0 ± 3.6 21.3 ± 2.1 29.0 ± 1.0 
R14A 4.3 ± 1.5 40.0 ± 3.6 19.7 ± 1.5 34.0 ± 3.6 R14A 6.7 ± 0.6 35.0 ± 1.0 19.3 ± 2.3 38.3 ± 1.2 
S16A 6.7 ± 0.6 39.3 ± 0.6 22.3 ± 2.1 30.7 ± 1.2 S16A 7.0 ± 1.4 41.5 ± 2.1 21.0 ± 0.0 30.0 ± 1.4 
S16E 4.3 ± 0.6 43.7 ± 0.6 22.0 ± 1.0 28.3 ± 1.5 S16E 6.5 ± 0.7 40.5 ± 2.1 21.5 ± 0.7 30.5 ± 0.7 
R17A 7.5 ± 0.7 40.0 ± 0.0 22.0 ± 0.0 30.0 ± 0.0 R17A 16.3 ± 1.2 36.3 ± 0.6 20.3 ± 2.1 26.3 ± 1.5 
S32A 16.0 ± 0.0 33.0 ± 2.8 22.0 ± 0.0 28.5 ± 2.1 S32A 15.5 ± 0.7 32.5 ± 2.1 22.5 ± 0.7 28.5 ± 0.7 
F25A 15.0 ± 0.0 33.5 ± 3.5 21.0 ± 1.4 29.0 ± 4.2 F25A 17.3 ± 2.3 29.3 ± 4.0 21.7 ± 1.2 32.0 ± 1.7 
W34A 17.0 ± 1.4 32.0 ± 0.0 20.5 ± 2.1 31.0 ± 4.2 W34A 16.0 ± 1.4 34.0 ± 1.4 21.0 ± 1.4 28.5 ± 0.7 
K63A 5.0 ± 0.0 39.0 ± 0.0 22.0 ± 0.0 33.0 ± 0.0 K63A 6.0 ± 1.0 41.3 ± 2.5 22.0 ± 1.0 29.0 ± 3.0 
R68/69A 20.0 ± 1.4 28.5 ± 0.7 19.5 ± 3.5 32.5 ± 2.1 R68/69A 6.7 ± 0.6 41.0 ± 1.7 23.0 ± 2.0 28.7 ± 2.1 
C113A 6.5 ± 0.7 34.5 ± 4.9 22.0 ± 0.0 36.5 ±3.5 C113A 6.7 ± 1.2 46.0 ± 3.0 20.7 ± 1.5 26.0 ± 4.4 
H59A 6.3 ± 0.6 37.3 ± 2.1 21.7 ± 2.5 34.3 ± 0.6 H59A 20.7 ± 2.3 25.7 ± 2.3 19.0 ± 1.7 35.3 ± 3.1 
H157A 6.0 ± 1.0 33.3 ± 0.6 19.3 ± 1.2 40.3 ± 2.3 H157A 16.0 ± 0.0 29.0 ± 0.0 20.0 ± 0.0 35.5 ± 0.7 
S154A 17.0 ± 0.0 33.0 ± 0.0 22.5 ± 0.7 27.5 ± 0.7 S154A 17.0 ± 2.6 34.7 ± 3.1 21.7 ± 0.6 26.0 ± 2.0 
L122A 7.0 ± 1.0 37.7 ± 2.1 21.7 ± 0.6 32.7 ± 1.5 L122A 6.3 ± 1.5 39.0 ± 3.0 22.0 ± 1.7 32.0 ± 3.0 
M130A 17.0 ± 2.0 30.7 ± 4.5 21.7 ± 0.6 30.3 ± 3.2 M130A 5.5 ± 0.7 43.5 ± 3.5 21.5 ± 0.7 28.5 ± 2.1 
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4.4 Thermal stability of Pin1 and its mutants 
 The thermal stability of Pin1 wild type and mutant proteins was investigated by 
monitoring changes in the intrinsic ellipticity by CD at 202 nm when these proteins 
were heated from 20 ºC to 90 ºC. Pin1 appeared fully unfolded when heated to 90 ºC 
as its CD spectra remained unchanged beyond 90 ºC (data not shown). The 
wavelength of 202 nm was used because changes in ellipticity were the greatest when 
Pin1 was heated from 20 ºC to 90 ºC (Figure 4-12). The temperature at which half of 
the protein molecules were unfolded was defined as melting temperature (Tm). 
Graphical presentation of the determination of Tm was shown in Figure 4-13, with 
C113A mutant as a representative. 
 
The Tm values of wild type and the various mutant proteins were shown in Table 
4-2 (page 110). Wild type Pin1 had a Tm of 58.4 ºC or 60.7 ºC in the absence or 
presence of phosphate, respectively. Interestingly, only mutants of the PPIase domain 
of Pin1, including mutants C113A, H59A, H157A, L122A, and M130A, experienced 
a left shift or decrease in Tm, indicating a decrease in thermal stability. All mutants of 
the WW domain had Tm values comparable to the wild type protein (Table 4-2; 
Figure 4-14). From the reported Pin1 crystal structure in complex with an Ala-Pro 
dipeptide (Ranganathan et al., 1997), the residues Cys-113, His-59, and His-157 are 
proposed to participate directly in the catalytic activity of Pin1. On the other hand, 
residues Leu-122 and Met-130 reside in the hydrophobic pocket that holds the proline 
residue of the Ala-Pro dipeptide, which is in proximity with the catalytic site. 
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Although residues Ser-154, Arg-68, Arg-69, and Lys-63 are located in the PPIase 
domain, mutations of these residues do not appear to destabilize the protein, as shown 
by their comparable Tm to the wild-type protein. Structurally speaking, these four 
residues (Ser-154, Arg-68, Arg-69, and Lys-63) reside at a flexible region mainly 
composed of the loop between α1 and β1, as well as between β3 and β4, which is 
further from the core region of the PPIase domain involving of the active site 
(Cys-113). Although residue Ser-154 is proposed to participate in the forming of an 
enzyme-substrate intermediate during the catalytic reaction, it may be relatively less 
critical to protein stability due to its structural location in this flexible region (Figure 
4-15). Hence, our data suggest that the PPIase domain, particularly the residues that 
reside in the core region of the catalytic site, is important in the overall stability of the 
Pin1 protein. 
 
In general, consistent with previous data reported by Bayer et al. (Bayer et al., 
2003), the presence of phosphate in the protein solution might slightly elevate the Tm  
values of the wild type and mutant proteins, although this may not be significant as 
seen in our data. Nevertheless, mutation of residues Arg-14, Lys-63, and 
Arg-68/Arg-69 to alanine seemed to abolish the stabilization by phosphate (Figure 
4-14). Thus, these residues may play an important role in phosphate binding, which is 
consistent with previously reported studies, as well as the secondary structure element 
analysis, discussed earlier in section 4.3. Although residues Arg-68, Arg-69, and 
Lys-63 do not directly contribute to the stability of the molecule, their role in substrate 
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specificity towards the pSer/Thr-Pro motif is undoubtedly significant, and their 
locations at the relatively flexible α1/β1 loop region may enable them to fulfill their 





Figure 4-12: Thermal denaturation of Pin1. Pin1 was heated from 20 ºC to 90 ºC with 1 ºC 
step intervals and the CD spectra was recorded. Ellipticity change was most drastic at the 
















































































































































































































Figure 4-13: Thermo-unfolding of Pin1. Pin1 wild-type (left) or mutant (middle) was heated from 20 ºC to 90 ºC. Melting temperature (Tm) was 
recorded as the temperature at which half the protein molecules was denatured. Thermo-unfolding curve of the C113A mutant was compared with 
wild-type (right), revealing a right shift of Tm of C113A mutant.
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     Table 4-2: Melting temperature (ºC) of Pin1. 
 In the absence of Pi In the presence of Pi 
WT 58.4 ± 0.1 60.7 ± 0.7 
R14A 58.6 ± 2.7 60.7 ± 1.1 
S16A 59.0 ± 0.5 61.4 ± 0.1 
S16E 59.3 ± 0.7 62.1 ± 0.2 
R17A 59.2 ± 0.1 62.4 ± 0.1 
S32A 58.1 ± 0.2 60.2 ± 0.2 
F25A 58.7 ± 0.2 61.2 ± 0.0 
W34A 59.5 ± 1.2 62.2 ± 0.8 
K63A 59.8 ± 0.5 60.0 ± 0.1 
R68/69A 60.4 ± 0.2 60.1 ± 0.2 
C113A 40.7 ± 1.6 48.8 ± 0.8 
H59A 46.0 ± 1.0 49.2 ± 1.6 
H157A 46.1 ± 2.4 49.1 ± 0.6 
S154A 60.6 ± 03 61.4 ± 0.4 
L122A 49.7 ± 0.3 53.0 ± 0.5 







Figure 4-14: Melting temperature (ºC) of Pin1. Measurements were 
done by circular dichroism (CD) analysis in the presence or absence of 
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Figure 4-15: Structural analysis of the residues critical for Pin1 stability. Pin1 crystal 
structure in complex with Ala-Pro dipeptide (PDB code: 1PIN) with the functionally 
important PPIase domain residues was shown. Residues in cyan denote residues critical for 
thermal stability of Pin1. Ala-Pro dipeptide was coloured in orange. Figure is generated by the 
MOLMOL program (http://hugin.ethz.ch/wuthrich/software/molmol/). 
 
4.5 The crystal structures of Pin1 mutants 
The Pin1 mutant structures were solved by X-ray crystallography to study the 
structure-function relationship of Pin1. Together with wild type, seven Pin1 mutants, 
including R14A, F25A, S32A, W34A, K63A, C113A, and M130A were crystallized， 
while the other mutants were failed to obtain the crystals. The crystal sizes range from 
0.3 × 0.3 mm to 0.3 × 0.8 mm (Figure 4-16). X-ray diffraction data were collected 
(Figure 4-17) and all mutant structures were solved by molecular replacement 
analysis and the resolutions were varied for different mutants. C113A and M130A 
structures were solved with a resolution up to 2.0 Å, whereas S32A and W34A 2.5 Å, 
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K63A 2.6 Å, F25A 2.7 Å, and R14A 3.4 Å (Table 4-4). The electron density maps of 
these mutants were clear to position the side chains. Thus the resolution of 2.0 Å to 
3.4 Å is sufficient to see the interaction of side chains. Ramachandran plot analyses 
were performed to check the stereochemical quality of the protein structures (Figure 
4-18). Table 4-3 shows a summary of the Ramachandran plot analysis. Percentage of 
residues that fell into the favored and allowed regions ranges from 79.2 % to 98.7 % 
and from 93.3 % to 99.3 %, respectively (Table 4-3). These ranges are generally 
regarded as acceptable. Among the mutants, crystals of R14A, F25A, and K63A 
belong to P3(1)21 space group, whereas crystals of S32A, W34A, C113A, and 
M130A belong to P4(3)2(1)2 space group, the same space group as wild type Pin1 
(Table 4-4). 
   




Figure 4-16: Crystals of Pin1 mutants. Top panel (left to right)—wild-type, M130A, S32A, W34A; bottom panel (left to right)—C113A, R14A, F25A, 
K63A. Space groups of P4 or P3 were indicated at the left bottom corner.
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Figure 4-18: Ramachandran plot analysis of W34A mutant. 96.6 % and 99.3 % of 
residues fall in the favored regions and allowed regions, respectively. 
 
Table 4-3: Summary of Ramachandran plot analysis.  





R14A 79.2 % 93.3 % 10 (Leu7, Ala14, Ser18, Ser19, Gln49, 
Arg54, Trp73, Asp112, Arg127, Gly128) 
F25A 93.2 % 96.6 % 5 (Leu7, Arg17, Ser18, Lys46, Pro70) 
S32A 96.0 % 97.3 % 4 (Leu7, Ser18, Gly20, Pro70) 
W34A 96.6 % 99.3 % 1 (Leu7) 
K63A 93.3 % 98.0 % 3 (Leu7, Met15, Ser18) 
C113A 98.0 % 99.3 % 1 (Leu7) 




Table 4-4: Crystallographic data and refinement statistics. 
Data set R14A F25A S32A W34A K63A C113A M130A 
Data collection        
Wavelength (Å) 1.1 1.5418 1.1 1.5418 1.5418 1.1 1.1 
Resolution Range (Å) 25.0-2.5 50.0-2.5 50.0-1.49 25.0-2.4 50.0-2.6 50.0-1.9 50.0-1.46 
Observation 28934 70855 378612 75174 38459 158858 372911 
Unique Reflections 7329 7431 52496 6722 6504 13863 29859 
Completeness (%) 
(working + test) 
94.9 95.6 99.8 95.5 92.6 99.8 98.7 
Rsym 9.5 8.6 6.2 8.2 8.3 7.3 6.0 
I/σ 15.8 22.8 15.0 14.9 16.8 8.4 11.7 






































Refinement        
Resolution Range (Å) 20.0-3.4 20.0-2.7 25.0-2.5 15.0-2.5 15.0-2.6 25.0-2.0 20.0-2.0 
R factor 22.5 24.5 24.9 21.7 23.5 23.9 25.5 
Rfree 32.2 30.6 33.2 29.0 29.5 28.3 28.7 
Protein atoms 1207 1209 1207 1204 1209 1212 1210 
Water molecules 59 205 126 158 125 129 181 
R.m.s.d. of Bonds (Å) 0.0070 0.0083 0.0153 0.0060 0.0081 0.0049 0.0050 
R.m.s.d. of Angles (º) 1.41 1.44 1.74 1.34 1.35 1.24 1.31 









Figure 4-20: Electron density maps of the Pin1 mutant K63A. Figures were generated by PyMOL. 
 117
4.6 Comparison of Pin1 mutant structures with the wild type structure 
All mutant structures were essentially grossly identical to the wild type structure 
(PDB code: 1PIN), with backbone R.M.S.D. values ranging from 0.272 Å to 0.642 Å 
(Figure 4-21). However, some side chain shifts were observed. Side chain shifts 
greater than the respective structure’s resolution were regarded as significant. These 
are shown in Figures 4-22 to 4-25 and summarized in Table 4-5. In the mutant R14A 
with a resolution of 3.4 Å, residues His-27, Gln-66, and Lys-117 exhibited significant 
side chain shift (Figure 4-22). Likewise, residues Arg-14, Arg-17, Arg-21, His-27, and 
Arg-68 for the F25A mutant (resolution of 2.7 Å) (Figure 4-23), as well as residues 
Arg-14, Arg-21, and His-27 for the S32A mutant (resolution of 2.5 Å) (Figure 4-24) 
also exhibited significant side chain shifts. Thus, besides those residues previously 
reported as important in substrate binding or catalytic activity of Pin1 (Arg-14, Arg-17, 
and Arg-68), side chain shifts in some other residues, such as Arg-21, His-27, Gln-66, 
and Lys-117, were observed as well. On the other hand, no other significant side chain 
shifts were observed in the Pin1 mutants W34A, K63A, C113A, and M130A, except 






                    C113A                    F25A                       K63A                      W34A 
  




Figure 4-21: Pin1 mutant backbone structures superimposed on the wild-type structure. Backbone structure in blue colour denotes wild-type 
structure. Red arrows indicate the mutated sites. RMSDs for the mutant structures are in reference to the wild type structure: M130A—0.316; 
R14A—0.642; S32A—0.442; W34A—0.292; C113A—0.272; F25A—0.645; K63A—0.454. Figures were generated by MOLMOL.
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Figure 4-22: Side chain shifts in the R14A mutant. Side chains in wild type and mutant 
proteins were coloured in green and red, respectively. Residues His-27, Gln-66, and Lys-117 
exhibited significant side chain shifts (> 3.4 Å, as indicated by black arrows). Figures were 







Figure 4-23: Side chain shifts in the F25A mutant. Side chains in wild type and mutant 
proteins were coloured in green and red, respectively. Residues Arg-14, Arg-17, Arg-21, 
His-27, and Arg-68 exhibited significant side chain shifts (> 2.7 Å, as indicated by black 









Figure 4-24: Side chain shifts in the S32A mutant. Side chains in wild type and mutant 
proteins were coloured in green and red, respectively. Residues Arg-14, His-27, and Arg-21 
exhibited significant side chain shifts (> 2.5 Å, as indicated by black arrows). Figures were 





Figure 4-25: Side chains of mutated residues for the W34A, K63A, C113A, and M130A mutants. W34A, K63A, C113A, and M130A mutants did not 
show significant side chain difference compared with the wild type, except at the mutated sites changed to alanine (indicated by black arrows). Only the 






Table 4-5: Summary of side chain shift comparisons between mutants and wild-type 
Pin1 (PDB code: 1PIN). Significant side chain shifts (> 2.0 Å) were indicated [in angstrom 
(Å)]. A blank entry indicates that insignificant or no side chain shifts were observed. “--” 
indicates corresponding residue mutated. 
 
Mutants R14A F25A C113A K63A W34A S32A M130A 
WW Domain 
R14 -- 5.00       4.20    
S16               
R17 2.55 3.75       2.32   
Y23               
F25   --           
S32           --   
W34         --     
PPIase Domain 
H59        
K63    --    
R68  4.41      
R69        
C113   --     
L122        
M130       -- 
S154        
H157        
Residues not reported in previous studies 
E12              
K13         
R21 3.38 4.86    3.83   
H27 4.57 4.69       3.82   
Q33         
E35         
Q66 3.48       
E87              
E100         
K117 3.76       
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4.7 Speculation on the important Pin1 residues for substrate binding 
The crystal structures of mutants R14A, F25A, S32A, W34A, K63A, C113A, and 
M130A were all very similar to that of wild type (PDB code: 1PIN) in both the 
backbone fold and side chain orientation. However, there were some observable shifts 
in side chain orientation in R14A, F25A, and S32A.  
 
In F25A, Arg-14, Arg-17, Arg-68, Arg-21, and His-27 are the most significantly 
shifted, apparently because these residues reside at the substrate binding site. Arg-14 
and Arg-17 are important residues in CTD peptide binding (Verdecia et al., 2000). 
Arg-14 are in van der Waals contact with Pro-3’ of the peptide whereas Arg-17, 
together with Ser-16 and Tyr-23, constitute the full binding module for the phosphate 
group on Ser-5’. As discussed earlier in the review of the WW domain studies (section 
1.8.2), residue Arg-14 may not be as important as Arg-17 in substrate binding 
specificity because it is also conserved in Group I WW domains which have no 
substrate preference for pSer/Thr-Pro motifs. Residue Arg-17 is important in substrate 
binding and specificity, but the side chain shift observed in the mutant structures may 
not sufficiently support this view for the following reasons. Firstly, Arg-17 lies in the 
loop between β1’ and β2’ which is rather flexible. As seen in the superposition of the 
mutant structures with wild type 1PIN, deviations were mainly observed in this region, 
although the overall structure deviations were insignificant (Figure 4-21). Secondly, 
the mutant structures were obtained with protein not in complex with any substrate 
peptide. Thus, it remains interesting to examine in future whether the Arg-17 side 
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chain shift indeed affects substrate binding. Nevertheless, previous studies using 
NMR titration with Cdc25 have mapped the peptide binding site at the β1’ and β2’ 
loop region, with chemical shift perturbations observed particularly at residues Arg-17 
and Typ-34 (Wintjens et al., 2001).  
 
Arg-68 resides in the α1/β1 loop in the PPIase domain and is involved in peptide 
binding and substrate selectivity. Mutation of Phe-25 to Ala causing side chain shift at 
Arg-68 suggests that Phe-25 could be one of the residues, if there are any other 
residues, causing the conformational change  in the α1/β1 loop when CTD peptide 
was in complex with the WW domain (from “closed” conformation to “open” 
conformation), as observed in the crystal structure of Verdecia et al. (Verdecia et al., 
2000). Residue His-27 was not previously reported as one that is in direct interaction 
with substrate peptide. Structurally, His-27 resides near the peptide binding interface 
at the WW domain, adjacent to Phe-25. Phe-25, together with Arg-14, is in van der 
Waals contact with Pro-3’ of CTD peptide. His-27 could therefore conceivably be 
involved in substrate binding. Other WW domain residues with observable shifts in 
side chain orientation include Arg-21. This residue, although not residing near any 
previously reported functional domains, may also participate in substrate binding. 
Interestingly, four out of five shifted residues observed are arginine residues (Arg-14, 
Arg-17, Arg-68, and Arg-21). Thus, deletion of Phe-25 affects the orientation of these 
positively charged residues, which in turn may disturb the binding of 
phosphosubstrates through these positively charged residues. This suggests the 
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important role of these charged residues in Pin1 function. However, these speculations 
need to be verified through binding assay and Pin1 structure in complex with 
substrate.  
 
In S32A mutant structure, similar with F25A, significant side chain shifts in 
Arg-14, Arg-21, and His-27 were observed. For R14A mutant, interestingly, besides 
His-27, mutation of Arg-14 also caused side chain shifts in Gln-66 and Lys-117. Same 
as Arg-68, Gln-66 resides in the α1/β1 loop in the PPIase domain. This suggested that 
besides Phe-25 as discussed earlier, Arg-14 could also be one of the residues causing 
the conformational change in the α1/β1 loop when CTD peptide was in complex with 
the WW domain. However, the resolution of R14A mutant structure (3.4 Å) was 
barely sufficient for the observation of side chain interaction (3.4 Å) so that the side 
chain shifts might not be significant.  
 
Among all our Pin1 mutants, previous studies showed that mutations at Trp-34 
abolished the substrate binding ability in vitro to the greatest extent. The affinity of 
the W34A mutant protein (as measured by Kd) towards CTD, drops from 10 μM of 
wild type to 180μM (Verdecia et al., 2000). A recent in vivo study done by Behrsin et 
al., has also demonstrated the importance of this residue, in which the W34A mutant 
failed to complement the function of ESS1 in ess1- strain of S. cerevisiae (Behrsin et 
al., 2006). Trp-34 is indeed in van der Waals contact with Pro-6’ in CTD peptide and 
hydrogen bonds with the side chain hydroxyl group of Ser-7’ (Verdecia et al., 2000). 
This residue is also highly conserved amongst the Pin1 homologues, as well as 
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amongst the Group IV WW domains. In our W34A mutant structure, no any side 
chain shift was observed. Thus, this indicates that the single localized perturbation of 
Trp-34 by alanine substitution is sufficient to abolish substrate binding, reinforcing 
the key role of Trp-34 in Pin1 function.  
 
Despite of these speculations, it is difficult to conclude on the importance of 
residues involved in substrate recognition from structures of the free mutant proteins 
alone. This is substantiated in studies on the W34A mutant, which shows that side 
change shifts in structures of the free protein may not directly correlate to the effects 
of the mutation on Pin1 function. This would require some complexes with substrate, 
multi-site mutations, and binding assays. Indeed interestingly, our preliminary data 
shows that the substrate peptide binding capacity of F25A and R17A mutants was 
abolished to a greater extent than W34A mutant (unpublished data). Arg-17 would be 
an interesting residue to investigate. Unfortunately we could not have grown its 
protein crystal under the same condition as the other mutants. Different properties of 
R17A mutant may partly explain its different crystallization condition. These remain 
to be further investigated. 
 
4.8 Speculations on the roles of residues in the PPIase domain 
Mutations to alanine at Cys-113 and Met-130 at the PPIase domain did not affect 
the global as well as local conformation of Pin1 (these mutant structures were solved 
with a resolution of 2.0) (Figure 4-26). It is noteworthy to point out that the original 
wild type structure is in complex with Ala-Pro dipeptide at the PPIase active site 
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(PDB code: 1PIN). Without complex with any peptide at the active site, our mutant 
structures can be considered as the “real” wild type structure. We should expect to see 
the bound and unbound forms. However, surprisingly, we did not find any difference 
in the catalytic binding region. In other words, the dissociation or binding of Ala-Pro 
dipeptide did not induce any conformational change in this region. This suggests that 
this binding groove in the PPIase domain could be very rigid. In this way, the binding 
groove could serve as a sort of selectivity filter for the substrates.  
 
The rigidity of the binding groove in the PPIase domain is consistent with the CD 
analyses. The CD analyses show that C113A, M130A, H59A, H157A, and L122A 
mutant proteins are all apparently less stable as revealed by their lower melting 
temperature (Figure 4-14). Hence, speculatively, disruption of these residues could 
have destroyed the core structure of the binding groove and rendered Pin1 unstable, 
thus diminishing its PPIase activity (Pastorino et al., 2006; Ranganathan et al., 1997; 
Ryo et al., 2001; Zhou et al., 2000), in addition to their direct role in Pin1’s catalytic 
mechanism as proposed (Ranganathan et al., 1997; Behrsin et al., 2006). As a minor 
point, these mutants may not be appropriate as catalytic inactive mutants for 



















Figure 4-26: Catalytic site of PPIase domain mutants. PPIase domain mutants C113A (A), 
M130A (B), and K63A (C) were superimposed with wild type structure 1PIN for comparison 
on the sulphate group and Ala-Pro dipeptide binding. Previously reported important side chain 
were shown with wild type and mutant side chains represented as green and yellow, 
respectively. Besides the mutated residues (indicated by black arrows), no other side chains 
shifts were observed. Figures were generated by PyMOL. 
 
On the other hand, mutation of Lys-63 to alanine did not affect the conformation 
of Pin1 as well (Figure 4-26). However, such a mutation did not lower Pin1 melting 
temperature (Figure 4-14), ruling out the possibility that the lost of function of K63A 
mutant was due to protein instability. This suggests that Lys-63, like Trp-34, may be 
functionally important to Pin1 in itself. This is consistent with the recent in vivo data 
reported by Behrsin et al. (Behrsin et al., 2006). Along the same line of investigation, 
Behrsin et al. have also reported that the negative charges of both Arg-68 and Arg-69 







not destabilize Pin1 (Figure 4-14), thus vindicating the previously reported data, 
although crystal structures of the R68A/R69A mutant is unfortunately not available.  
 
4.9 Modeling of Pin1 WW domain mutants in complex with the CTD peptide 
 Modeling of the WW domain Pin1 mutant structures in complex with the CTD 
peptide was next carried out based on the published wild type Pin1 crystal structure 
(PDB code: 1F8A) (Verdecia et al., 2000). 1F8A is the structure in which the Pin1 
WW domain is in complex with the doubly phosphorylated CTD peptide 
(Tyr-pSer2’-Pro-Thr-pSer5’-Pro-Ser). By comparing these mutant structures with 
1F8A, some generalized predictions on the phosphopeptide binding site of the WW 
domain mutants would be possible.  
 
 First, the backbone structures of the Pin1 WW domain mutants, including R14A, 
F25A, S32A, and W34A, were superimposed with 1F8A. All these mutants have a 
similar folding compared to 1F8A, except at the regions of α1/β1 loop and β1’/β2’ 
loop, as reported previously for 1PIN (Figure 4-27, highlighted by dotted red circles). 
This is expected since 1PIN was the model structure used for molecular replacement 
to solve all the mutant structures in this study, and the mutants show identical folding 





























Figure 4-27: Backbone superposition of Pin1 crystal structures with 1F8A. (A) Superposition of 
wild-type structure 1PIN with 1F8A. 1PIN is the Pin1 crystal structure (magenta) in which the PPIase 
domain is in complex with Ala-Pro dipeptide (cyan), whereas 1F8A is the Pin1 crystal structure (blue) 
that the WW domain is in complex with CTD phosphopeptide (green). (B) Superposition of WW 
domain mutants R14A (magenta), F25A (red), S32A (cyan), and W34A (yellow) with 1F8A. Dotted 





Comparison of the side chains at the CTD binding site of of 1F8A with wild type 
Pin1 (PDB code: 1PIN) revealed several side chain shifts, including residues Arg-14, 
Ser-16, Arg-17, and Tyr-23 (Table 4-6). In comparing the various WW domain 
mutants and 1F8A, the same set of side chain shifts was observed (Table 4-6). Most of 
the shifts were similar to that of 1PIN. However, shifts of residue Arg-14 in F25A and 
S32A mutants, as well as that of residue Arg-17 in R14A, F25A and S32A mutants, 
were significantly different from that of 1PIN. The orientation of residue His-27 was 
observed to be shifted significantly in R14A, F25A, and S32A mutants (Figure 4-28). 
Since residue His-27 in the native structure is outside of the CTD binding region, 
whether it is involved in the substrate binding could not be addressed in this modeling 
exercise. However, residue His-27 could potentially be involved in substrate binding 
based on its location near to the CTD binding groove. As discussed before, although 
Arg-14 and Arg-17 reside in the binding groove, whether their side chain shifts in the 
mutants are biologically relevant is inconclusive.  
 
4.10 Cellular localization of Pin1 
 The Pin1 mutants were expressed in mammalian cells to study the effect of the 
mutations on their biological functions in vivo, particularly to examine their cellular 
localization. Previous studies have revealed that Pin1 is predominantly localized in 
the nucleus or nuclear speckles. Moreover, an intact WW domain and an active 
catalytic site are essential for this nuclear localization (Lu et al., 1996b; Rippmann et 
al., 2000). There is no defined nuclear localization signal (NLS) in Pin1’s sequence 
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(Lu et al., 2002a; Ranganathan et al., 1997). Thus, nuclear localization or nuclear 
import of Pin1, could have resulted from its interaction with cellular substrates (Lu et 
al., 2002a; Lu, 2003; Rippmann et al., 2000). Studying the localization of Pin1 
mutants might therefore delineate the important residues in Pin1 function and 
substrate interaction in vivo.  
 
 
Table 4-6: Summary of side chain comparison between mutants and wild-type Pin1 
(PDB code: 1F8A). Significant side chain shifts (> 2.0 Å) were indicated [in angstrom (Å)]. 
A blank entry indicates that insignificant or no side chain shifts were observed. “--” indicates 
corresponding residue mutated. Side chain orientations which are significantly different from 
WT are underlined and highlighted in bold letters. 
 
WT / Mutants WT 
(1PIN) 
R14A F25A C113A K63A W34A S32A M130A 
Previously reported residues important for substrate binding at WW Domain 
R14 2.61 -- 3.87  5.48 5.51 4.77 3.48 5.70 
S16 3.78 5.12 4.13  3.57 4.46 7.04 6.00 3.61 
R17 10.09 8.30 7.65  9.84 8.81 9.92 7.85 9.84 
Y23 2.88 2.46 2.67   2.33   2.30 
F25     --           
S32             --   
W34           --     
Residues not reported in previous studies 
E12 4.57 3.53 2.98  3.15 4.43 4.72 3.15 
K13   4.18      
R21        6.21 
H27 4.96 0.71 0.38 4.75 4.11 5.01 2.18 4.85 
Q33     3.32    
E35        6.94 
Q66         
E87 2.84 2.70 3.49  4.56 3.42 3.02 3.06 
E100          





Figure 4-28: Superposition of Pin1 mutants with 1F8A at WW domain in complex with CTD peptide (Tyr-pSer2’-Pro-Thr-pSer5’-Pro-Ser). (A) R14A, (B) F25A, 
(C) S32A, and (D) W34A. Green denotes 1F8A; pink denotes mutants. Mutated side chains were shown. Besides the mutated site chains, site chain shifts at Arg-14 and 




D W34A C S32A 
 
 136
Constructs of EGFP-tagged wild type Pin1 and the mutants (R14A, S16A, S16E, 
R17A, S32A, W34A, R68A/R69A, F25A, K63A, C113A, H59A, H157A, S154A, 
L122A, M130A) were first transiently expressed in HEK 293T cell lines. As shown 
by Western blot analysis of all lysates (Figure 4-29), all the EGFP-Pin1 constructs 
could be expressed in mammalian cells. The EGFP-Pin1 constructs were then 
transfected into HeLa cells and the subcellular localization of Pin1 was examined 20 
hours after transfection by fluorescence microscopy. Consistent with previous 
findings, wild type Pin1 predominantly localized in the nucleus (Figure 4-30). Most of 
the mutations did not affect Pin1’s nuclear localization, as shown in Figure 4-30 (only 
a few mutants were shown as representatives). However, W34A mutant had a diffused 
staining pattern of green fluorescence throughout the cells, thus validating the 
important role of residue Trp-34 in substrate binding in vivo. Interestingly, the C113A 
mutant protein was also preferentially localized in the nucleus, contradicting to the 
previous report (Rippmann et al., 2000). Moreover, for all mutants except W34A, it 
was observed that only some cells had Pin1 localization in the nuclear speckles. One 
possible explanation for this would be that the function and the cellular localization of 
Pin1 could be cell cycle dependent. Thus, cells were then synchronized to specific cell 
cycle stages using different drug treatments. Treatments with double thymidine and 
hydroxyurea block arrest cells at the early G1/S and late G1/S phase, respectively, 
whereas serum starvation arrests cells at G0 phase. Cells that had a diffused green 
fluorescence pattern throughout the cells were quantified. As shown in Figure 4-31, 
mutation of Trp-34 to Ala (W34A) causes more mutant Pin1 to diffuse to the 
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cytoplasm compared to wild type in all the three cell cycle stage arrested populations. 
Translocation of C113A may also be cell cycle dependent. In addition, apoptosis in 
the majority of cells expressing the C113A mutant (which could induce apoptosis, 
consistent with previous report (Rippmann et al., 2000) could have biased the 
quantification. No obvious change in cellular localization was observed for the other 
mutants, namely R14A, S32A, F25A, K63A, and M130A.  
 
Taken together, our data showed the importance of residue Trp-34 in Pin1 cellular 
function. Trp-34 may play a very critical role in substrate binding. Importantly, a 
single localized disruption of this residue, as discussed in session 4.7, would be 
sufficient to alter Pin1’s function. However, whether the localization of wild type Pin1 








Figure 4-29: Pin1 overexpression in HEK 293T cells. 293T cells were transiently transfected with various EGFP-Pin1 constructs as indicated and the 
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Figure 4-30: Cellular localization of Pin1. Wild-type or mutant EGFP-Pin1 constructs were transiently transfected into HeLa cells. 20 hours after 



















Figure 4-31: Subcellular localization of Pin1 during different cell cycle stages. HeLa cells grown on cover slips 
were transiently transfected with various EGFP-Pin1 constructs followed by serum starvation, double-thymidine 
block, and hydroxyurea treatments. Localization of Pin1 was observed and imaged under a fluorescence microscope. 
Numbers of cells showing more diffused green fluorescence to the cytosol in the various mutants were counted (A).  
Experiments were done twice and data shown are the averages of the two readings. (B) Fluorescence microscopy 
































































4.11 A proposed model for Pin1’s mechanism of action—a new “two-step 
induced-fit” binding model 
 
 In the previous proposed “induced-fit” model based on the two available crystal 
structures of Pin1, 1PIN and 1F8A (Ranganathan et al., 1997; Verdecia et al., 2000), the 
α1/β1 loop with the tripartite basic cluster composing of Lys-63, Arg-68, and Arg-69 
would act as a selectivity filter for phosphate. Upon phosphosubstrate binding to the 
catalytic site, the α1/β1 loop is induced to flip towards the bound substrate to adopt a 
“closed” conformation. Such a closed conformation encloses a cleft nicely fitting for a 
phosphorylated substrate (Ranganathan et al., 1997). According to this model, Pin1 
would be in an “open” conformation when there is no substrate bound to the catalytic 
site. However and interestingly, the structures of the Pin1 mutants we have solved， 
which have no peptide recruited to the catalytic site, revealed a closed conformation. 
On the other hand, the Pin1 crystal structure 1F8A, which is in complex with CTD 
peptide at the WW domain, adopts an open conformation in the α1/β1 loop at the 
catalytic domain. A twist of the triple-stranded antiparallel β-sheet in WW domain was 
observed in this crystal structure as well (Verdecia et al., 2000). We also observed side 
chain shifts in the α1/β1 loop region when residues in the WW domain binding region 
were mutated (Arg-14 and Phe-25) (section 4.7). This has suggested an inherit mobility 
of this selectivity filter in solution through a twist in the WW domain upon binding or 
dissociation of a phosphopeptide at either the WW domain or PPIase domain, or both.  
 
Taken together, these (the two reported crystal structures and our mutant structures) 
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suggest that peptide binding to the WW domain could stimulate the α1/β1 loop to be 
opened for the entering of substrate into the catalytic site (first step). The opening of the 
α1/β1 loop is through global conformational changes induced by the β-sheet twist in the 
WW domain, particularly involving Phe-25 and Arg-14. According to our data, 
mutation of Arg-14 and Phe-25 caused side chain shifts in Gln-66 and Arg-68, which 
reside in the α1/β1 loop region. Thus, peptide binding to the WW domain and 
particularly its interaction with Arg-14 and Phe-25 could be critical to induce the 
conformational change of the α1/β1 loop for the entering of substrate into the catalytic 
site. The entering of substrate into the catalytic site in turn causes another 
conformational change, resulting in the “closed” positioning of the α1/β1 loop (second 
step). Hence, we propose a “two-step induced-fit” binding model (Figure 4-32). The 
closing of the α1/β1 loop could be driven by the electrostatic interaction between the 
phosphate and the three positively charge residues at the α1/β1 loop (Lys-63, Arg-68, 
Arg-69) when phosphopeptide binds to the catalytic site.  
 
In the model proposed by Bayer et al. through NMR studies, the Pin1 WW domain 
and PPIase domain are non-interacting in solution prior to substrate binding. These two 
domains are connected by a flexible linker comprising of Asn-40 to Gly-49. Upon 
substrate binding to the concave binding site in the WW domain (mainly through the 
hydrophobic and electrostatic interactions), the two domains are then brought together 
to interact with each other (Bayer et al., 2003). In accordance with our proposed 




Figure 4-32: The “Two-step induced-fit” binding model. α1/β1 loop of Pin1 can adopt either 
closed or open conformation. Pin1 in itself is in closed conformation. Upon binding of substrate, 
as illustrated here with CTD peptide, the α1/β1 loop is induced to open (step I) to allow the 
binding of another substrate or another recognition motif within the same molecule, as 
illustrated with Ala-Pro dipeptide and sulphate ion. Recruitment of substrate at the PPIase 
active site induces a conformational change, causing α1/β1 loop to refold into a closed 
conformation (step II), followed by cis-trans isomerization of the oriented peptidyl prolyl 







interaction of the two domains could be mediated through the flexible linker upon 
peptide binding to the concave binding site to trigger a global conformational change, 
leading to the α1/β1 loop to subsequently adopt an “open conformation” for substrate 
entering into PPIase catalytic site. Not only in all the NMR structures, the flexibility of 
the linker is also shown in the two crystal structures 1PIN and 1F8A, and all our seven 
mutant structures, in which no electron density map could be observed in this region. 
 
The “two-step induced-fit” model may explain the case of the Pin1 homologue 
Ca-Ess1, which adopts a closed conformation without any phosphate recruited to the 
catalytic site (Li et al., 2005). Compared to the Pin1 crystal structure 1PIN (with a PEG 
molecule recruited to the WW domain), the Ca-Ess1 structure is one without any bound 
substrate. Thus, the recruitment of a PEG molecule in 1PIN may mimic substrate 
binding to the WW domain, inducing the α1/β1 loop to open up and enabling the 
Ala-Pro dipeptide and sulphate to enter the catalytic site, followed by the closure of the 
loop. In the case of Ca-Ess1, the α1/β1 loop is not induced to open to grant the entry of 
phosphate. This can also explain the NMR data reported by Bayer et al., which showed 
that in either the presence or absence of sulphate ion, the α1/β1 loop remained in the 
closed conformation (Bayer et al., 2003).  
 
 In our model, the second step of peptide binding to the catalytic site and the closure 
of the α1/β1 loop may trigger second time of the β-sheet twist in the WW domain. This 
may cause the release of the substrate peptide from the WW domain, getting ready for 
the recruitment of another substrate peptide. The recruitment of second substrate 
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peptide in turn causes the opening of the α1/β1 loop to release the substrate peptide 
with its isomerized peptidyl prolyl bond from the catalytic site. This would allow the 
entering of another substrate peptide for isomerization. In this way, the cycle repeats for 
the carrying out Pin1’s function in cis/trans-isomerization of its substrates. This has 
also pointed out that Pin1 may work on different peptidyl prolyl bonds within the same 
protein molecule, or different molecules interacting as a complex.  
 
 On the other hand, as discussed earlier based on our mutant structures and melting 
temperature analyses, the core catalytic site itself would be a very rigid structure. Thus, 
the catalytic site could act as a sort of selectivity filter for the substrates (section 4.8). 
The substrate selectivity in this binding groove for Ala-Pro dipeptide could even be 
more important than the phosphate selectivity at the α1/β1 loop. From our preliminary 
data, full-length Pin1 do not necessarily bind phosphorylated peptides better than the 
non-phosphorylated counterparts, although phosphorylated peptides are in general more 
favoured by the Pin1 WW domain (not published). This also raises the same question 
whether both the WW and PPIase domains work on the same peptidyl prolyl bond 
sequentially, or they work on different peptidyl prolyl bonds within the same protein 
molecule, or different molecules interacting as a complex. If the selectivity of this 
binding groove at the PPIase domain core region is critical, this could also explain why 
it is difficult for researchers to come out with a consensus sequence around the 
Ser/Thr-Pro motif. 
 
At a more fundamental level of understanding, whether Pin1 could catalyze the 
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isomerization of the proline bond in the sequence of pSer/Thr-Pro remains debatable. 
The idea of pSer/Thr-Pro being the preferred substrate of Pin1 came from the Pin1 
crystal structure in complex with the Ala-Pro dipeptide and a sulphate ion 
(Ranganathan et al., 1997). The vicinity and orientation of the dipeptide and sulphate 
ion suggested a substrate preference for pSer/Thr-Pro motifs. However, there is no 
direct evidence or direct visualization of this substrate preference. Frequently, another 
proline residue could be found a few amino acid residues downstream of the 
Ser/Thr-Pro motif in Pin1’s substrates (Table 1-2). Hence it would be interesting to 
examine also whether the peptidyl prolyl bond orientated at the binding groove in the 
core catalytic site is the proline residue in the so-called Ser/Thr-Pro motif or is the 
proline lying downstream of the motif. In the later scenario, the pSer/Thr-Pro motif 
itself may bind to the WW domain, whereas the basic cluster at the α1/β1 loop can 
serve as second layer for substrate specificity towards the pSer/Thr-Pro motif. However, 
the PPIase domain would catalyze the isomerization of the prolyl bond downstream of 
pSer/Thr-Pro motif and not within.  
 
Thus, in future studies, it would be important to work on Pin1 structure in complex 
with longer peptides or even the whole substrate protein that interact with the PPIase 
catalytic domain as well as WW domain peptide binding site to address all those 
uncertainties. A detailed peptide screen for optimized binding to full-length Pin1, and 
the WW or the PPIase domain alone would be helpful to further define the full 
recognition motif for Pin1. 
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CHAPTER 5: CONCLUSION AND FUTURE PERSPECTIVES 
 
Pin1 is known to play important roles in a diverse array of cellular processes 
including cell cycle control, transcription and splicing regulation, DNA replication 
checkpoint control, DNA damage response, neuronal survival, and germ cell 
development. It functions by catalyzing peptidyl-prolyl isomerization and causes 
conformational changes of its substrates. Deregulation of Pin1 has been implicated in 
pathological conditions including cancers and neurodegenerative diseases. Structurally 
and functionally, Pin1 is a novel prolyl isomerase that specifically catalyzes the 
cis/trans-isomerization of proline within the sequence of phosphorylated Ser/Thr-Pro. 
In spite of knowledge in the wide range of its substrates, very little is known about its 
catalytic mechanism and how exactly it interacts with its biological substrates.   
 
 Structural studies on Pin1 mutants in this project aim to better understand Pin1’s 
mechanism of action. Several Pin1 WW domain and PPIase domain mutants have been 
generated, cloned and expressed in E. coli. Large scale protein expression and 
purification were carried out for subsequent CD analysis and X-ray crystallography.  
 
 Melting temperature (Tm) analysis by CD revealed that only the PPIase domain 
mutants, including C113A, H59A, H157A, L122A, and M130A, but not the WW 
domain mutants, had lowered Tm. Interestingly, these residues reside at the core 
structure of the active site in the PPIase domain, and they might contribute to the 
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stability to the core structure of Pin1. Loss of PPIase activity in these PPIase domain 
mutants could thus be due either to the direct participation of these residues in Pin1’s 
catalytic activity, or simply a result of the destabilization of the Pin1 core structure. 
Further investigation to verify the nature of these PPIase domain mutants is necessary 
before classifying them as PPIase-dead mutants. Moreover, CD data also supported the 
role of Pin1 residues Arg-14, Arg-17, Lys-63, Arg-68, and Arg-69 in phosphopeptide 
binding. 
 
 The structures of seven Pin1 mutants, including R14A, F25A, S32A, W34A, K63A, 
C113A, and M130A, were solved by molecular replacement analysis. The structures of 
these mutants were in general grossly similar to wild type Pin1. The R14A, F25A, and 
S32A mutant structures exhibited side chain shifts in residues Arg-14, Arg-17, Arg-21 
His-27, Gln-66, Arg-68, and Lys-117, suggesting their possible involvement in 
substrate binding. Interestingly, side chain shifts observed in the PPIase domain 
(Gln-66 and Arg-68) in R14A and F25A mutants suggested that Arg-14 and Phe-25 in 
the WW domain could be important to cause a conformational change at the α1/β1 loop 
upon substrate binding to the WW domain. The Trp-34 in the WW domain was 
previously identified as an important residue in substrate binding. On the other hand, 
Lys-63, together with another two basic residues Arg-68 and Arg-69, resides in the 
α1/β1 loop, acting as the selectivity filter for phosphopeptide. Interestingly, deleterious 
mutations of Trp-34 and Lys-63 did not perturb the structural positioning of any other 
nearby residues. This implies that single, localized perturbations of Trp-34 or Lys-63 
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would be sufficient to abolish Pin1 function. These data further support the critical role 
of these two residues in Pin1 function. The biological importance of Trp-34 was further 
revealed by Pin1 localization studies, in which substitution of Trp-34 with Ala caused 
Pin1 to translocate from the nucleus to the cytoplasm.  
 
It is noteworthy to point out that X-ray structures of free proteins are not sufficient 
to describe the properties of mutants and to conclude the importance of residues 
involved in substrate recognition. This would require some complexes with substrate, 
multi-site mutations, and binding assays. In vivo studies would also help to verify the 
biological significance of those important residues. Nevertheless, our information on 
these side chain shifts would be useful in future studies and aid in identifying potential 
residues important in substrate binding. 
 
 Superpositions of mutant structures with 1PIN (in which Pin1 is in complex with 
Ala-Pro dipeptide at the PPIase domain catalytic site) and with 1F8A (in which Pin1 is 
in complex with CTD phosphopeptide at WW domain) provided little information on 
the role of various side chains in peptide binding. However, in our mutant structures, 
where there was no Ala-Pro dipeptide bound to the catalytic site, did not exhibit any 
conformational difference at the catalytic site when compared which 1PIN. This 
observation suggested that the catalytic site could be a very rigid structure to serve as a 
selectivity filter for substrates. 
 
 Our crystal structures of Pin1 mutants revealed a closed conformation of the α1/β1 
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loop in all the mutants, although there is no sulphate or phosphate ion recruited to the 
PPIase catalytic site. This result contradicts the previously proposed “induced-fit” 
model. Thus, together with our mutant structures, a “two-step induced-fit” model is 
proposed to explain Pin1’s mechanism of action. In our model, the Pin1 WW domain 
and PPIase domain interact weakly, and the α1/β1 loop is in a closed conformation. 
Upon binding of substrate to the WW domain, the two domains were promoted to 
interact with each other and the β-sheet twist in WW domain triggers a global 
conformational change, causing the α1/β1 loop to open (step I). This open 
conformation allows the binding of another substrate or another recognition motif 
within the same molecule. Recruitment of substrate to the PPIase active site then 
induces another conformational change, causing the α1/β1 loop to refold into a closed 
conformation (step II). This is then followed by cis-trans isomerization of the peptidyl 
prolyl bonds, leading to substrate conformation change for the regulation of substrate 
activity. We also proposed that the core catalytic site itself could be a very rigid 
structure to serve as a critical selectivity filter for substrates. It could even be more 
critical than the phosphate selectivity at the α1/β1 loop.  
 
Together, these studies provide a deeper understanding of how Pin1 interacts with 
its biological target proteins. Although X-ray crystal structures alone are not sufficient 
to describe the properties of mutantsSeveral speculative points remained to be 
addressed: I) whether both WW and PPIase domains work on the same peptidyl prolyl 
bond sequentially, or they act simultaneously on different peptidyl prolyl bonds within 
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the same protein molecule or in different molecules interacting as a complex; and II) 
whether Pin1 catalyzes the isomerization of the proline bond in the sequence of 
pSer/Thr-Pro motif itself. To address these issues in the future, more Pin1 structures in 
complex with its biological substrates or longer peptides would be necessary. It would 
also be necessary to further verify our hypothesized “two-step induced-fit” binding 
model by titrating Pin1 with CTD peptide and Ala-Pro dipeptide for the examination of 
the resonance change at the α1/β1 and β1’/β2’ loop regions. Alternatively, enzyme 
kinetics studies would be useful. Tools, such as NMR-based methods, could be 
developed to visualize the dynamic movements of the functional domains upon the 
binding of longer peptides or even the whole substrate molecule. Lastly, a detailed 
peptide screen for optimal binding to full-length Pin1, WW domain, or PPIase domain 
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A Matlab script--Analyzing and plotting graphs for Pin1’s melting temperature 
(Written by Mr. Xu Yuhong) 
 
%read data into column vectors 




%cubic smoothing spline with appropriate smoothing parameter 
f=csaps(a,b,0.001); %0.01 is a smoothing parameter 
  
%find the minimum and maximum value 
m1=fnmin(f,[min(a) max(a)]); %minimum 
g=f; 
g.coefs=-f.coefs; 
m2=-fnmin(g,[min(a) max(a)]); %maximum 
  






%display the value of the roots; show the plot 
disp('the root is:'); disp(rts); 
%subplot(1,2,1); 
fnplt(f,2), hold on, plot(a,b,'x'),hold on; 
plot([min(a) max(a)],[m1 m1],'--'),hold on; 
plot([min(a) max(a)],[m2 m2],'--'),hold on; 
plot([min(a) max(a)],[mean mean],'--'),hold on; 
set(gca,'xlim',[20 90]); 
xlabel('Temperature (^o C)');ylabel('deg.cm^2.dmol^{-1}'); 
legend(strcat('Tm = ', num2str(rts(1)))); 




%xlabel('Temperature (^o C)');ylabel('degcm^2dmol{-1}'); 
title('Thermo-unfolding Curve of WT'); 
 
 
 
